<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title>Frontiers in Immunology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Immunol.</abbrev-journal-title>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fimmu.2023.1268851</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Transcriptome analysis reveals molecular mechanisms of lymphocystis formation caused by lymphocystis disease virus infection in flounder (<italic>Paralichthys olivaceus</italic>)</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Honghua</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2523315"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Sheng</surname>
<given-names>Xiuzhen</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/542602"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tang</surname>
<given-names>Xiaoqian</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/581965"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xing</surname>
<given-names>Jing</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/482089"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chi</surname>
<given-names>Heng</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/219420"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhan</surname>
<given-names>Wenbin</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/282072"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Laboratory of Pathology and Immunology of Aquatic Animals, Key Laboratory of Mariculture, Ministry of Education (KLMME), Ocean University of China</institution>, <addr-line>Qingdao</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Function Laboratory for Marine Fisheries Science and Food Production Processes, Qingdao National Laboratory for Marine Science and Technology</institution>, <addr-line>Qingdao</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Iddya Karunasagar, Nitte University, India</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Subhendu Otta, Central Institute of Brackishwater Aquaculture (ICAR), India; Jingguang Wei, South China Agricultural University, China</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Xiuzhen Sheng, <email xlink:href="mailto:xzsheng@ouc.edu.cn">xzsheng@ouc.edu.cn</email>
</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>05</day>
<month>10</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>14</volume>
<elocation-id>1268851</elocation-id>
<history>
<date date-type="received">
<day>28</day>
<month>07</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>18</day>
<month>09</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Zhang, Sheng, Tang, Xing, Chi and Zhan</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Zhang, Sheng, Tang, Xing, Chi and Zhan</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Lymphocystis disease is frequently prevalent and transmissible in various teleost species worldwide due to lymphocystis disease virus (LCDV) infection, causing unsightly growths of benign lymphocystis nodules in fish and resulting in huge economic losses to aquaculture industry. However, the molecular mechanism of lymphocystis formation is unclear. In this study, LCDV was firstly detected in naturally infected flounder (<italic>Paralichthys olivaceus</italic>) by PCR, histopathological, and immunological techniques. To further understand lymphocystis formation, transcriptome sequencing of skin nodule tissue was performed by using healthy flounder skin as a control. In total, RNA-seq produced 99.36%-99.71% clean reads of raw reads, of which 91.11%-92.89% reads were successfully matched to the flounder genome. The transcriptome data showed good reproducibility between samples, with 3781 up-regulated and 2280 down-regulated differentially expressed genes. GSEA analysis revealed activation of Wnt signaling pathway, Hedgehog signaling pathway, Cell cycle, and Basal cell carcinoma associated with nodule formation. These pathways were analyzed to interact with multiple viral infection and tumor formation pathways. Heat map and protein interaction analysis revealed that these pathways regulated the expression of cell cycle-related genes such as <italic>ccnd1</italic> and <italic>ccnd2</italic> through key genes including <italic>ctnnb1</italic>, <italic>lef1</italic>, <italic>tcf3</italic>, <italic>gli2</italic>, and <italic>gli3</italic> to promote cell proliferation. Additionally, cGMP-PKG signaling pathway, Calcium signaling pathway, ECM-receptor interaction, and Cytokine-cytokine receptor interaction associated with nodule formation were significantly down-regulated. Among these pathways, <italic>tnfsf12</italic>, <italic>tnfrsf1a</italic>, and <italic>tnfrsf19</italic>, associated with pro-apoptosis, and <italic>vdac2</italic>, which promotes viral replication by inhibiting apoptosis, were significantly up-regulated. Visual analysis revealed significant down-regulation of <italic>cytc</italic>, which expresses the pro-apoptotic protein cytochrome C, as well as <italic>phb</italic> and <italic>phb2</italic>, which have anti-tumor activity, however, <italic>casp3</italic> was significantly up-regulated. Moreover, <italic>bcl9</italic>, <italic>bcl11a</italic>, and <italic>bcl-xl</italic>, which promote cell proliferation and inhibit apoptosis, were significantly upregulated, as were <italic>fgfr1</italic>, <italic>fgfr2</italic>, and <italic>fgfr3</italic>, which are related to tumor formation. Furthermore, RNA-seq data were validated by qRT-PCR, and LCDV copy numbers and expression patterns of focused genes in various tissues were also investigated. These results clarified the pathways and differentially expressed genes associated with lymphocystis nodule development caused by LCDV infection in flounder for the first time, providing a new breakthrough in molecular mechanisms of lymphocystis formation in fish.</p>
</abstract>
<kwd-group>
<kwd>flounder (<italic>Paralichthys olivaceus</italic>)</kwd>
<kwd>lymphocystis disease virus</kwd>
<kwd>RNA-Seq</kwd>
<kwd>transcriptome</kwd>
<kwd>lymphocystis formation</kwd>
<kwd>molecular mechanism</kwd>
</kwd-group>
<contract-num rid="cn001">32273163, 31872599, 31730101</contract-num>
<contract-sponsor id="cn001">National Natural Science Foundation of China<named-content content-type="fundref-id">10.13039/501100001809</named-content>
</contract-sponsor>
<counts>
<fig-count count="8"/>
<table-count count="2"/>
<equation-count count="0"/>
<ref-count count="82"/>
<page-count count="18"/>
<word-count count="7916"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Comparative Immunology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>Lymphocystis disease virus (LCDV) is a member of the genus <italic>lymphocystivirus</italic> of the <italic>Iridoviridae</italic> family and the causative agent of lymphocystis disease (<xref ref-type="bibr" rid="B1">1</xref>). LCDV has infected more than 140 species of marine and freshwater fish worldwide, including flounder (<italic>Paralichthys olivaceus</italic>), which is economically important in Asian countries such as Japan, Korea, and China, causing great economic losses (<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B3">3</xref>). Fish with lymphocystis disease develop benign cauliflower-like nodules on the skin, gills, fins, mouth, and some internal organs (<xref ref-type="bibr" rid="B4">4</xref>). LCDV mainly infects fibroblasts, and a large number of fibroblasts exist in the connective tissue of the skin, so the skin is the main target tissue where the presence of lymphocystis nodules is usually observed (<xref ref-type="bibr" rid="B4">4</xref>). These nodules vary in size, present creamy white or pink (vascularly congested), and are either dispersed or aggregated into clusters. Histopathologically, the nodules contain a large number of hypertrophied cells (i.e., lymphocystis cells) developed from the infected fibroblasts in the connective tissue underlying the epithelium, which may be up to 100 times the size of normal cells in fish, with a thick hyaline capsule outside the cell membrane, expanded and irregular nuclei, and cytoplasm containing a large number of viral particles and inclusion bodies (<xref ref-type="bibr" rid="B5">5</xref>&#x2013;<xref ref-type="bibr" rid="B8">8</xref>). Although lymphocystis disease is a self-limiting and rarely fatal disease, and the lesions can heal and the fish may recover after a few weeks, the benign nodules lead to nonmarketability of diseased fish, poor growth, and secondary bacterial infections that can lead to mortality (<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B3">3</xref>). To elucidate the mechanism of LCDV infection and develop effective preventive measures, considerable research has focused on LCDV-host interaction. Remarkably, a 27.8 kDa protein on the cell membrane of flounder gill (FG) cells is identified as the cellular receptor for LCDV entry, which is further confirmed to be voltage-dependent anion channel protein 2 (VDAC2) and receptor of activated protein C kinase 1 (RACK1), and the two receptors mediate LCDV invasion of host cells through interacting with a 32kDa viral adhesion protein (VAP) of LCDV that encoded by LCDV ORF038 gene, using the caveolae/raft mediated endocytosis pathway into FG cells (<xref ref-type="bibr" rid="B9">9</xref>&#x2013;<xref ref-type="bibr" rid="B12">12</xref>). In addition to fibroblasts, which are considered to be the main target cells of LCDV, some studies have shown that gilthead seabream (<italic>Sparus aurata</italic>) hepatocytes, macrophages, and <italic>in vitro</italic>-cultured leukocytes are involved in LCDV infection (<xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B14">14</xref>). Recently, LCDV has been found to infect peripheral blood IgM<sup>+</sup> B cells of flounder, and IgM<sup>+</sup> B cells also express the 27.8 kDa receptor protein and support LCDV replication, so B cells may be the vector of LCDV transmission among tissues (<xref ref-type="bibr" rid="B15">15</xref>). However, the process by which LCDV infects host cells and proliferates intracellularly resulting in hypertrophied cells and then the formation of lymphocytsis nodule, and the underlying mechanism regulating lymphocytsis formation, remains to be clarified.</p>
<p>In mammals, viral infections are a major contributor to nodules and even malignant tumors. Studies have shown that the known viruses, e.g., Epstein&#x2013;Barr virus (EBV), Merkel cell polyomavirus (MCPyV), hepatitis B virus (HBV), hepatitis C virus (HCV), human T-lymphotropic virus 1 (HTLV-1), human papillomaviruses (HPVs) and Kaposi sarcoma-associated herpesvirus (KSHV), can promote tumorigenesis through common host cellular targets and pathways (<xref ref-type="bibr" rid="B16">16</xref>). These viruses have been found to support their proliferation by controlling the cell cycle, apoptosis, autophagy, DNA damage, immune escape (viral protein homologs that regulate immune mechanisms), and biosynthesis and metabolism (<xref ref-type="bibr" rid="B17">17</xref>). In fish, few viruses cause nodules but LCDV, so there are fewer studies on the mechanisms of lymphocystis nodule formation. Previously, microarray experiments were used to track the formation of lymphocystis cells, and it was concluded that apoptosis and division were inhibited in the ventral fins of LCDV-infected flounder and further formed lymphocystis cells by cell fusion (<xref ref-type="bibr" rid="B5">5</xref>), but the mechanism of nodule formation remains to be systematically investigated.</p>
<p>RNA-Seq is a technique for the detection of transcriptome expression levels in samples by high-throughput sequencing (<xref ref-type="bibr" rid="B18">18</xref>) and has become a revolutionary tool for transcriptional and genomic characterization (<xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B20">20</xref>). This technique is very sensitive and can accurately detect rare transcripts, with a very wide range of detection and high sensitivity to gene expression at high or very low levels (<xref ref-type="bibr" rid="B18">18</xref>). Using RNA-Seq techniques, we have studied gill tissue differentially expressed genes (DEGs) in flounder at one week post LCDV infection, providing preliminary insights into fish defense mechanisms against LCDV (<xref ref-type="bibr" rid="B6">6</xref>).</p>
<p>In this study, the flounder (<italic>P. olivaceus</italic>) naturally developed skin and fin nodules for about one month in a fish farm in Rizhao, Shandong province of China. The flounder was first detected for LCDV infection by using polymerase chain reaction (PCR), quantitative real-time PCR (qRT-PCR), histopathological and indirect immunofluorescence assay (IFA) technique. Subsequently, transcriptomic data of skin nodule tissues of LCDV-infected flounder were obtained by high-throughput sequencing with the skin of healthy flounder as control, the pathways and differentially expressed genes associated with nodule formation were analyzed, and expression patterns of focused genes in various tissues were also analyzed.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<label>2</label>
<title>Materials and methods</title>
<sec id="s2_1">
<label>2.1</label>
<title>Experimental fish and sampling</title>
<p>Healthy and diseased flounder (250 &#xb1; 50 g) were taken from the fish farm, and cultured in a continuous aerated and flow-through seawater system at a temperature of 21 &#xb1; 1&#xb0;C. Before all, flounders were tested by PCR to confirm LCDV-free in the healthy fish and LCDV infection in the diseased fish. For RNA-Seq, skin nodule tissues from four diseased fish and skin tissues from four healthy fish, named LS (LCDV-infected) and CS (control) groups respectively, were randomly selected and placed in liquid nitrogen for rapid freezing. For qRT-PCR, flounder were anesthetized with 100 mg/mL MS-222 (Sigma, MO, USA), and the liver, spleen, head kidney, trunk kidney, hindgut, gills, and skin were taken from these fish. The samples were rapidly immersed in RNAlater (Thermo Scientific, Waltham, Massachusetts, USA) and stored at -80&#xb0;C.</p>
</sec>
<sec id="s2_2">
<label>2.2</label>
<title>Histological preparation and indirect immunofluorescence assay</title>
<p>Skin nodule tissue from diseased fish was aseptically excised, washed with phosphate-buffered saline (PBS), fixed in Bouin&#x2019;s solution, and then washed several times with 70% ethanol. The tissue was subsequently dehydrated in a series of increasing concentrations of ethanol, cleared in xylene, and embedded in paraffin by conventional procedures. The 5 &#x3bc;m-thick sections were cut, and stained with hematoxylin-eosin (H-E) and histologically observed by Zeiss microscope (Oberkochen, Germany).</p>
<p>For IFA, at least three paraffin sections of each fish were subjected to IFA using mouse anti-LCDV 32kDa VAP monoclonal antibody (Mab) 1C8 previously prepared in our laboratory (<xref ref-type="bibr" rid="B21">21</xref>). Briefly, the sections were dewaxed using xylene and rehydrated in decreasing concentrations of ethanol, finally washed in PBS. The antigen repair of the sections was carried out by using modified sodium citrate antigen repair solution (50&#xd7;) (1:50, Beyotime, Shanghai, China) at 95&#xb0;C for 20 min, followed by incubation with 4% bovine serum albumin (BSA) in PBS at 37&#xb0;C for 1 h. Mouse anti-LCDV 32kDa VAP Mab 1C8 (1:200 diluted in PBS) was incubated as primary antibody at 37&#xb0;C for 1 h. After three washes with PBST (PBS containing 0.05% Tween-20) for 5 min each, FITC-conjugated goat-anti-mouse Ig (1:1000 diluted in PBS, Sigma, MO, USA) was incubated as secondary antibody for 45 min at 37&#xb0;C. Subsequently, DAPI (1:1000 diluted in PBS, Thermo Scientific, Waltham, Massachusetts, USA) was stained for 15 min at room temperature in the dark to visualize the cell nucleus. Non-immune mouse serum replacing primary antibody was used as a negative control. Finally, slides were mounted with extended glass mounting medium (Thermo Scientific, Waltham, Massachusetts, USA) and fluorescence imaging was performed under an immunofluorescence microscope (Zeiss, Oberkochen, Germany).</p>
</sec>
<sec id="s2_3">
<label>2.3</label>
<title>Transmission electron microscopy</title>
<p>Skin lymphocystis nodule tissue less than 1 mm<sup>3</sup> in volume was excised, rinsed with PBS to remove blood and mucus, and then fixed with 2.5% glutaraldehyde in 0.1 mol/L PBS (pH 7.4) for 2 h and post-fixed with 1% osmium acid in PBS at 4&#xb0;C. The samples were dehydrated in gradient alcohol, embedded in Epon812 embedding agent, and sectioned on an ultrathin microtome. Finally, the ultra-thin sections were stained with uranyl acetate-lead citrate and observed by transmission electron microscope.</p>
</sec>
<sec id="s2_4">
<label>2.4</label>
<title>Genetic level detection of LCDV</title>
<p>Total DNA was extracted from the skin nodule tissues of LS groups and the skin of CS groups. LCDV ORF038 gene encoding the LCDV 32 kDa VAP was used for PCR amplification (F: 5&#x2019;-ATGTCTGTCATAGGATTTACTCTACAA-3&#x2019;, R: 5&#x2019;-AAAAGTCAAATAAAATATTAAAATCATT-3&#x2019;). 20 &#x3bc;L PCR reaction system: DNA template 1 &#xb5;L, each primer 1 &#xb5;L, Ex Taq DNA polymerase 0.5 &#xb5;L (TaKaRa, Japan), Ex Taq buffer 2.5 &#xb5;L, dNTPs 2 &#xb5;L, ddH<sub>2</sub>O 12 &#x3bc;L. Reaction procedure: 95&#xb0;C for 5 min, 35 amplification cycles (95&#xb0;C for 30 sec, 60&#xb0;C for 30 sec, 72&#xb0;C for 1 min), 72&#xb0;C for 10 min. The PCR product size was detected by 1.0% agarose gel electrophoresis.</p>
<p>To determine the replication of LCDV in various tissues of the diseased flounder, total DNA was extracted from liver, spleen, head kidney, trunk kidney, hindgut, gill and skin tissues, followed by 50 ng DNA as template with a pair of specific primers (F: 5&#x2019;- TCTTGTTCAGCATTTACTTCTCGGC -3 &#x2018; and R: 5&#x2019;- TCTTCTCCTTTAGATGATTTCCC -3&#x2019;) (<xref ref-type="bibr" rid="B11">11</xref>) for qPCR amplification of the LCDV ORF038 gene fragment. Each sample was tested four times, and non-infected samples served as negative controls. After amplification, a melting curve analysis was undertaken to guarantee that there was no non-specific amplification. Finally, the LCDV copy number was determined by calculating the Ct value from the previously established standard curve (<xref ref-type="bibr" rid="B11">11</xref>). The data was expressed as mean log<sub>10</sub> copies/50 ng DNA.</p>
</sec>
<sec id="s2_5">
<label>2.5</label>
<title>cDNA library construction and sequencing</title>
<p>Total RNA was isolated from flounder skin nodule tissue according to the manufacturer&#x2019;s protocol using the Trizol kit (Invitrogen, Carlsbad, CA, USA). The quality of the RNA was determined using an Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA, USA) and RNase-free agarose gel electrophoresis. Afterward, the mRNA was enriched by magnetic beads with Oligo(dT) and then interrupted with First Strand Synthesis Reaction Buffer. To synthesize the first strand of cDNA in the M-MuLV reverse transcriptase system, the fragmented mRNA was used as a template, and random oligonucleotides were used as primers. The RNA strand was then degraded with RnaseH, and the cDNA second strand was synthesized with dNTPs under the DNA polymerase I system. Sequencing connectors were ligated and poly(A) was added. The purified double-stranded cDNA was end-repaired. Approximately 200 bp cDNAs were screened with AMPure XP beads, amplified by PCR, and then sequenced using Illumina HiSeq2500 in Gene Denovo Biotechnology Co (Guangzhou, China).</p>
</sec>
<sec id="s2_6">
<label>2.6</label>
<title>Filtering and alignment of clean reads</title>
<p>Reads obtained from the sequencing machines include raw reads containing adapters or low-quality bases. These raw reads will affect the following assembly and analysis. Reads were therefore further filtered using fastp (version 0.18.0) to obtain high-quality clean reads (<xref ref-type="bibr" rid="B22">22</xref>). The criteria were as follows: eliminating adapter-containing reads, reads with more than 10% of unknown nucleotides (N), and reads with more than 50% of low-quality (Q-value &#x2264; 20) bases.</p>
<p>The ribosomal RNA (rRNA) database was mapped using the short reads alignment program Bowtie2 (version 2.2.8) (<xref ref-type="bibr" rid="B23">23</xref>) before the rRNA-mapped reads were eliminated. The remaining clean reads were then used for gene abundance estimation and assembly. Using HISAT (version 2.2.4) with &#x201c;-rna-strandness RF&#x201d; and other default options, paired-end clean reads were mapped to the reference genome after creating an index of the reference genome (<xref ref-type="bibr" rid="B24">24</xref>).</p>
</sec>
<sec id="s2_7">
<label>2.7</label>
<title>Differentially expressed genes and gene set enrichment analysis</title>
<p>Differential gene expression between the CS and LS groups was analyzed using DESeq2 software (<xref ref-type="bibr" rid="B25">25</xref>). Genes with false discovery rate (FDR) &lt; 0.05 and absolute fold change (FC) &#x2265; 2 were differentially expressed genes (DEGs). To determine whether a collection of genes in particular KEGG pathways had significant differences in the two groups, gene set enrichment analysis (GSEA) was carried out using the tools GSEA and MSigDB (<xref ref-type="bibr" rid="B26">26</xref>). In a nutshell, the SinaltoNoise normalization method was used to input the gene expression matrix and rank genes, and enrichment scores and p-value were calculated in default parameters.</p>
</sec>
<sec id="s2_8">
<label>2.8</label>
<title>Protein-protein interaction and pathway visualization</title>
<p>A protein-protein interaction (PPI) network was identified using String (version 10) (<xref ref-type="bibr" rid="B27">27</xref>), which determined genes as nodes and interactions as lines in a network. A core and hub gene biological interaction was shown using Cytoscape (version 3.7.1) software by visualizing the network file (<xref ref-type="bibr" rid="B28">28</xref>). Pathway visualization and data integration of genes based on gene expression using PATHVIEW (<ext-link ext-link-type="uri" xlink:href="https://pathview.uncc.edu/">https://pathview.uncc.edu/</ext-link>, accessed on 30 May 2023) (<xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B30">30</xref>).</p>
</sec>
<sec id="s2_9">
<label>2.9</label>
<title>Quantitative real-time PCR</title>
<p>Briefly, 1 &#x3bc;g of total RNA was extracted from liver, spleen, head kidney, trunk kidney, hindgut, gill, and skin tissues and reverse transcribed into cDNA in a 20 &#x3bc;L reaction system. 2 &#x3bc;L of cDNA was then used as a template. Primer Premier 5 was used to design specific primers for the pathway-related genes in focus. Expression levels were normalized using flounder <italic>&#x3b2;-actin</italic> as an internal reference. The qRT-PCR was performed using SYBR green Master Mix (Roche, Switzerland) in a LightCycler<sup>&#xae;</sup> 480 II Real Time System (Roche, Switzerland). The 2<sup>&#x2212;&#x25b3;&#x25b3;Ct</sup> method was used to analyze the expression levels of the selected genes. The primers used in this section are shown in <xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>. Each sample was run in quadruplicate.</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>Sequence information for primers used in this study.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="center">Gene</th>
<th valign="middle" align="center">Accession No.</th>
<th valign="middle" align="left">Primer Sequence (5&#x2019;-&gt;3&#x2019;)</th>
<th valign="middle" align="center">Length (bp)</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" rowspan="2" align="left">&#x3b2;-actin</td>
<td valign="middle" rowspan="2" align="left">XM_020109620.1</td>
<td valign="middle" align="left">F: GTCCCTGTATGCCTCTGGTC</td>
<td valign="middle" rowspan="2" align="left">215</td>
</tr>
<tr>
<td valign="middle" align="left">R: TGTCACGCACGATTTCCCTC</td>
</tr>
<tr>
<td valign="middle" rowspan="2" align="left">wnt5a</td>
<td valign="middle" rowspan="2" align="left">XM_020096312.1</td>
<td valign="middle" align="left">F: ACTTCCGCAAGGTGGGTGAT</td>
<td valign="middle" rowspan="2" align="left">178</td>
</tr>
<tr>
<td valign="middle" align="left">R: GAGCCCGTGCTTTGGTTCTT</td>
</tr>
<tr>
<td valign="middle" rowspan="2" align="left">ctnnb1</td>
<td valign="middle" rowspan="2" align="left">XM_020090668.1</td>
<td valign="middle" align="left">F: AGAAACGTCTGTCGGTGGA</td>
<td valign="middle" rowspan="2" align="left">161</td>
</tr>
<tr>
<td valign="middle" align="left">R: GCCGTAGGCTGATGGGTAT</td>
</tr>
<tr>
<td valign="middle" rowspan="2" align="left">lef1</td>
<td valign="middle" rowspan="2" align="left">XM_020101320.1</td>
<td valign="middle" align="left">F: ACTAAACGCCTTCATGCTC</td>
<td valign="middle" rowspan="2" align="left">160</td>
</tr>
<tr>
<td valign="middle" align="left">R: TTCCTTGCGGGCTAACT</td>
</tr>
<tr>
<td valign="middle" rowspan="2" align="left">tcf3</td>
<td valign="middle" rowspan="2" align="left">XM_020107767.1</td>
<td valign="middle" align="left">F: CCTGGATTTCAGTGCGATGT</td>
<td valign="middle" rowspan="2" align="left">109</td>
</tr>
<tr>
<td valign="middle" align="left">R: GCCGCTACGCTCGTCTATT</td>
</tr>
<tr>
<td valign="middle" rowspan="2" align="left">gli2</td>
<td valign="middle" rowspan="2" align="left">XM_020109184.1</td>
<td valign="middle" align="left">F: TTTACGAGACCAACTGCCACTG</td>
<td valign="middle" rowspan="2" align="left">147</td>
</tr>
<tr>
<td valign="middle" align="left">R: GCTTCTGCTCCCGAGAACACT</td>
</tr>
<tr>
<td valign="middle" rowspan="2" align="left">ccnd1</td>
<td valign="middle" rowspan="2" align="left">XM_020080206.1</td>
<td valign="middle" align="left">F: TACTGTGCTGCGAGGTGGACT</td>
<td valign="middle" rowspan="2" align="left">116</td>
</tr>
<tr>
<td valign="middle" align="left">R: GTTGGGAGACGGTAGGTAGGTTT</td>
</tr>
<tr>
<td valign="middle" rowspan="2" align="left">ccnd2</td>
<td valign="middle" rowspan="2" align="left">XM_020078448.1</td>
<td valign="middle" align="left">F: CATGTTCCTCGCATCCAAAT</td>
<td valign="middle" rowspan="2" align="left">114</td>
</tr>
<tr>
<td valign="middle" align="left">R: ACCACCAGTTCCCATTCCAG</td>
</tr>
<tr>
<td valign="middle" rowspan="2" align="left">bcl9</td>
<td valign="middle" rowspan="2" align="left">XM_020089951.1</td>
<td valign="middle" align="left">F: GGAATCCTGTTCCTGGCTCAA</td>
<td valign="middle" rowspan="2" align="left">181</td>
</tr>
<tr>
<td valign="middle" align="left">R: GCCTCCGTCTTCGGTTTAG</td>
</tr>
<tr>
<td valign="middle" rowspan="2" align="left">bcl11a</td>
<td valign="middle" rowspan="2" align="left">XM_020088700.1</td>
<td valign="middle" align="left">F: ACCACCCGAGTGCCTTTGA</td>
<td valign="middle" rowspan="2" align="left">182</td>
</tr>
<tr>
<td valign="middle" align="left">R: TGTCTGGAATGGCTGGAGTAA</td>
</tr>
<tr>
<td valign="middle" rowspan="2" align="left">bcl-xl</td>
<td valign="middle" rowspan="2" align="left">XM_020111495.1</td>
<td valign="middle" align="left">F: TGGTGGAGTTCTTTATCAGTTACA</td>
<td valign="middle" rowspan="2" align="left">133</td>
</tr>
<tr>
<td valign="middle" align="left">R: TTGACCAGCAAGCCATTACT</td>
</tr>
<tr>
<td valign="middle" rowspan="2" align="left">fgfr1a</td>
<td valign="middle" rowspan="2" align="left">XM_020107117.1</td>
<td valign="middle" align="left">F: CTGAAGGAAGGTCACCGTATG</td>
<td valign="middle" rowspan="2" align="left">194</td>
</tr>
<tr>
<td valign="middle" align="left">R: GAGTATTGGTCCAGAGGCAC</td>
</tr>
<tr>
<td valign="middle" rowspan="2" align="left">fgfr3</td>
<td valign="middle" rowspan="2" align="left">XM_020108467.1</td>
<td valign="middle" align="left">F: TCCTATGGTGTGTTGTTGTGG</td>
<td valign="middle" rowspan="2" align="left">138</td>
</tr>
<tr>
<td valign="middle" align="left">R: GTACAGCTCATGTGTGCAGTTTG</td>
</tr>
<tr>
<td valign="middle" rowspan="2" align="left">fzd2</td>
<td valign="middle" rowspan="2" align="left">XM_020113633.1</td>
<td valign="middle" align="left">F: CGATATGCTCAGCGGCGT</td>
<td valign="middle" rowspan="2" align="left">108</td>
</tr>
<tr>
<td valign="middle" align="left">R: AGGAACGAGGTCCCGATGAA</td>
</tr>
<tr>
<td valign="middle" rowspan="2" align="left">fzd8</td>
<td valign="middle" rowspan="2" align="left">XM_020113464.1</td>
<td valign="middle" align="left">F: ACAACTGCTCCAACTGTTTACTG</td>
<td valign="middle" rowspan="2" align="left">138</td>
</tr>
<tr>
<td valign="middle" align="left">R: ACGAGTCCAGGGTCTTGCC</td>
</tr>
<tr>
<td valign="middle" rowspan="2" align="left">pik3r1</td>
<td valign="middle" rowspan="2" align="left">XM_020082241.1</td>
<td valign="middle" align="left">F: TAGAGCCCTTGCCGAGAT</td>
<td valign="middle" rowspan="2" align="left">136</td>
</tr>
<tr>
<td valign="middle" align="left">R: TGGAGCAGCCTGACTTTCAC</td>
</tr>
<tr>
<td valign="middle" rowspan="2" align="left">fgfr2</td>
<td valign="middle" rowspan="2" align="left">XM_020088824.1</td>
<td valign="middle" align="left">F: GATCCACGCTGGGAGTTT</td>
<td valign="middle" rowspan="2" align="left">128</td>
</tr>
<tr>
<td valign="middle" align="left">R: TCACGGCTTCCTTAGGTTT</td>
</tr>
<tr>
<td valign="middle" rowspan="2" align="left">mtor</td>
<td valign="middle" rowspan="2" align="left">XM_020088845.1</td>
<td valign="middle" align="left">F: CAGCGTCAGAACAACCAAGCA</td>
<td valign="middle" rowspan="2" align="left">169</td>
</tr>
<tr>
<td valign="middle" align="left">R: AGCAGTGAAGGTGTCCCCA</td>
</tr>
<tr>
<td valign="middle" rowspan="2" align="left">fzd9</td>
<td valign="middle" rowspan="2" align="left">XM_020095313.1</td>
<td valign="middle" align="left">F: CGAAGCCCACAGCAACTAC</td>
<td valign="middle" rowspan="2" align="left">136</td>
</tr>
<tr>
<td valign="middle" align="left">R: CCCAGAGTCCATACTCCCTAC</td>
</tr>
<tr>
<td valign="middle" rowspan="2" align="left">lrp5</td>
<td valign="middle" rowspan="2" align="left">XM_020104881.1</td>
<td valign="middle" align="left">F: CATTGACTATGTAGACCATCGAC</td>
<td valign="middle" rowspan="2" align="left">150</td>
</tr>
<tr>
<td valign="middle" align="left">R: CAGTAGATAAAATCTTGGTATTGTG</td>
</tr>
<tr>
<td valign="middle" rowspan="2" align="left">tcf7l2</td>
<td valign="middle" rowspan="2" align="left">XM_020083352.1</td>
<td valign="middle" align="left">F: ACGAGACAACTATGCGGCTAAC</td>
<td valign="middle" rowspan="2" align="left">167</td>
</tr>
<tr>
<td valign="middle" align="left">R: GCCCGAACAAGGCACGAC</td>
</tr>
<tr>
<td valign="middle" rowspan="2" align="left">mdm4</td>
<td valign="middle" rowspan="2" align="left">XM_020086872.1</td>
<td valign="middle" align="left">F: ACAGAGGCAGCACATAGTCCA</td>
<td valign="middle" rowspan="2" align="left">140</td>
</tr>
<tr>
<td valign="middle" align="left">R: CAGCGTCAGAACAACCAAGCA</td>
</tr>
<tr>
<td valign="middle" rowspan="2" align="left">ruvbl1</td>
<td valign="middle" rowspan="2" align="left">XM_020086807.1</td>
<td valign="middle" align="left">F: AGGTGCCCTTCTGTCCTAT</td>
<td valign="middle" rowspan="2" align="left">117</td>
</tr>
<tr>
<td valign="middle" align="left">R: CCTTGGTTTCTTTGATACGC</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s2_10">
<label>2.10</label>
<title>Statistical analysis</title>
<p>Statistical Products and Services Solutions (SPSS) software (version 20.0, IBM, BY, USA) was used to analyze the obtained data. One-way analysis of variance (ANOVA) was used to analyze the results of viral proliferation, and the expression levels of genes in each tissue. Values were deemed significant at <italic>p</italic> &lt; 0.05.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<label>3</label>
<title>Results</title>
<sec id="s3_1">
<label>3.1</label>
<title>Infection characteristics of LCDV in flounder</title>
<p>The healthy and naturally diseased flounder were tested for LCDV. Cauliflower-like nodules were evident on the skin and fins of the diseased flounder (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1A</bold>
</xref>), and a specific LCDV ORF038 gene band of 933 bp was amplified from the diseased fish but not in the healthy fish skin (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1B</bold>
</xref>). The lymphocystis cells within skin connective tissue had hypertrophic features with basophilic inclusion bodies in the cytoplasm by H-E staining (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1D</bold>
</xref>), and a large number of viral particles were observed in the cytoplasm by transmission electron microscopy (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1E</bold>
</xref>). Moreover, the cytoplasm of lymphocystis cells was positive for LCDV as shown by IFA (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1F</bold>
</xref>). The qRT-PCR results indicated that LCDV copy number was detected in all tested tissues of the affected fish, with the highest copy number of 3.0&#xd7;10<sup>7</sup>/50 ng DNA in the skin, followed by the gills (4.5&#xd7;10<sup>4</sup>), trunk kidney (1.5&#xd7;10<sup>4</sup>), hindgut (1.1&#xd7;10<sup>4</sup>), spleen (6.7&#xd7;10<sup>2</sup>) and liver (3.0&#xd7;10<sup>2</sup>), and the lowest in the head kidney (9.0&#xd7;10<sup>1</sup>), while the controls had no LCDV proliferation (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1C</bold>
</xref>). All these results confirmed that the healthy fish were not infected by LCDV, while the diseased fish were naturally infected with LCDV, so they could be used for the next experiment.</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>LCDV detection in flounder. <bold>(A)</bold> Clinical symptoms of naturally LCDV-infected flounder, and the healthy fish as control. The diseased fish showed obvious nodules on skin and fin (red box). <bold>(B)</bold> PCR assay of the skin of four healthy and diseased flounder, respectively. 933bp LCDV specific band was amplified in all LCDV-infected (LS) groups but not in control (CS) groups. M: DL5000 DNA Marker. <bold>(C)</bold> Copy numbers of LCDV in different tissues of the diseased flounder and control fish. Mean viral copy numbers were represented in the log<sub>10</sub> scale. <bold>(D)</bold> H-E staining of skin nodule tissue of diseased fish. Basophilic inclusion bodies (black arrows) were present in the hypertrophic lymphocystis cells. Scale bar = 50&#xb5;m. <bold>(E)</bold> Transmission electron microscope observation of skin nodule tissue. A large number of viral particles appeared in the cytoplasm (black arrows) of lymphocystis cells. Scale bar = 1&#xb5;m. <bold>(F)</bold> skin nodule tissue fluorescently stained with mouse anti-LCDV 32kDa VAP Mab. Positive green signal was observed in the cytoplasm; non-immune mouse serum as negative control showing no green signal; cell nucleus stained with DAPI (blue); Scale bar = 50&#x3bc;m.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-14-1268851-g001.tif"/>
</fig>
</sec>
<sec id="s3_2">
<label>3.2</label>
<title>Transcriptome sequencing quality</title>
<p>Clean reads with 40994192, 46893012, 40908092, and 49650708 were obtained from the CS group, and 52683364, 42481640, 47979600, and 39471322 were obtained from the LS group, respectively. Sequence data for CS-1, CS-2, CS-3, CS-4, LS-1, LS-2, LS-3, and LS-4 have been submitted to the NCBI database under accession numbers SAMN36345915, SAMN36345916, SAMN36345917, SAMN36345918, SAMN36345919, SAMN36345920, SAMN36345921, and SAMN36345922, respectively. The (guanine and cytosine) GC percentages for all samples ranged from 47.52%-49.46%, with reads over 96.0% for Q20 and 91.0% for Q30 for each sample, indicating high sequencing quality. Also, 91.11%-92.89% of the sequence reads were successfully localized to the flounder genome (<xref ref-type="table" rid="T2">
<bold>Table&#xa0;2</bold>
</xref>).</p>
<table-wrap id="T2" position="float">
<label>Table&#xa0;2</label>
<caption>
<p>Summary of sequencing and assembly statistics for the transcriptome data.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="center">Samples</th>
<th valign="middle" align="center">Raw reads</th>
<th valign="middle" align="center">Clean reads (%)</th>
<th valign="middle" align="center">Q20 (%)</th>
<th valign="middle" align="center">Q30 (%)</th>
<th valign="middle" align="center">GC (%)</th>
<th valign="middle" align="center">Total mapped (%)</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="left">CS-1</td>
<td valign="middle" align="left">41131938</td>
<td valign="middle" align="left">40994192 (99.67%)</td>
<td valign="middle" align="left">97.90%</td>
<td valign="middle" align="left">94.08%</td>
<td valign="middle" align="left">47.93%</td>
<td valign="middle" align="left">37936874 (92.84%)</td>
</tr>
<tr>
<td valign="middle" align="left">CS-2</td>
<td valign="middle" align="left">47039530</td>
<td valign="middle" align="left">46893012 (99.69%)</td>
<td valign="middle" align="left">97.94%</td>
<td valign="middle" align="left">94.17%</td>
<td valign="middle" align="left">49.08%</td>
<td valign="middle" align="left">43447661 (92.86%)</td>
</tr>
<tr>
<td valign="middle" align="left">CS-3</td>
<td valign="middle" align="left">41052022</td>
<td valign="middle" align="left">40908092 (99.65%)</td>
<td valign="middle" align="left">97.91%</td>
<td valign="middle" align="left">94.09%</td>
<td valign="middle" align="left">48.85%</td>
<td valign="middle" align="left">37935490 (92.89%)</td>
</tr>
<tr>
<td valign="middle" align="left">CS-4</td>
<td valign="middle" align="left">49796204</td>
<td valign="middle" align="left">49650708 (99.71%)</td>
<td valign="middle" align="left">96.92%</td>
<td valign="middle" align="left">91.48%</td>
<td valign="middle" align="left">48.33%</td>
<td valign="middle" align="left">45105990 (91.25%)</td>
</tr>
<tr>
<td valign="middle" align="left">LS-1</td>
<td valign="middle" align="left">52959048</td>
<td valign="middle" align="left">52683364 (99.48%)</td>
<td valign="middle" align="left">97.34%</td>
<td valign="middle" align="left">92.83%</td>
<td valign="middle" align="left">49.46%</td>
<td valign="middle" align="left">48216058 (91.85%)</td>
</tr>
<tr>
<td valign="middle" align="left">LS-2</td>
<td valign="middle" align="left">42753138</td>
<td valign="middle" align="left">42481640 (99.36%)</td>
<td valign="middle" align="left">97.15%</td>
<td valign="middle" align="left">92.35%</td>
<td valign="middle" align="left">47.52%</td>
<td valign="middle" align="left">38516818 (91.11%)</td>
</tr>
<tr>
<td valign="middle" align="left">LS-3</td>
<td valign="middle" align="left">48225006</td>
<td valign="middle" align="left">47979600 (99.49%)</td>
<td valign="middle" align="left">97.35%</td>
<td valign="middle" align="left">92.83%</td>
<td valign="middle" align="left">48.58%</td>
<td valign="middle" align="left">43851911 (91.71%)</td>
</tr>
<tr>
<td valign="middle" align="left">LS-4</td>
<td valign="middle" align="left">39663740</td>
<td valign="middle" align="left">39471322 (99.51%)</td>
<td valign="middle" align="left">97.36%</td>
<td valign="middle" align="left">92.83%</td>
<td valign="middle" align="left">49.00%</td>
<td valign="middle" align="left">36186336 (92.00%)</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s3_3">
<label>3.3</label>
<title>Differentially expressed genes after LCDV infection</title>
<p>When we analyzed the expression of different genes in LCDV-infected flounder versus healthy fish, a total of 6061 DEGs were observed. Hierarchical clustering of differential gene expression patterns was performed, and a heat map was used to present the clustering results. The heat map results showed that four biological replicates were clustered together in each group, indicating good concordance (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2A</bold>
</xref>). The volcano map results demonstrated that 3781 DEGs were significantly up-regulated and 2280 DEGs were significantly down-regulated after LCDV infection (FDR &lt; 0.05, FC &#x2265; 2) (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2B</bold>
</xref>).</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>DEGs in flounder after LCDV infection. <bold>(A)</bold> The heat map represented the expression levels of those genes that were differentially expressed, as well as the normalization of gene expression using the z-score to construct hierarchical clusters of different samples. Two highly differential clusters were observed: one for genes that were inhibited following LCDV infection and the other for genes that were overexpressed following infection. <bold>(B)</bold> Volcano map of differentially expressed genes. Red represented up-regulated genes, blue represented down-regulated genes, and grey represented no differences.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-14-1268851-g002.tif"/>
</fig>
<p>The qRT-PCR of random 10 DEGs validated these RNA-Seq results. The qRT-PCR results for the tested genes showed similar expression patterns as observed in the RNA-Seq data (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3</bold>
</xref>), indicating that the RNA-seq results were reliable.</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Confirmation of RNA-seq data by qRT-PCR. The results were presented as the means &#xb1; SEM of four individuals.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-14-1268851-g003.tif"/>
</fig>
</sec>
<sec id="s3_4">
<label>3.4</label>
<title>Lymphocystis nodule-related activated pathways and genes in response to LCDV infection</title>
<p>The KEGG pathways that hosted the gene set of flounder after LCDV infection were analyzed using the GSEA method. In total, 32 active signaling pathways were found (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4A</bold>
</xref>). Among them, those related to nodule formation mainly included Wnt signaling pathway (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4B</bold>
</xref>) and Hedgehog signaling pathway (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4C</bold>
</xref>) in Signal transduction, Cell cycle (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4D</bold>
</xref>) in Cell growth and death, and Basal cell carcinoma (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4E</bold>
</xref>) in Diseases. In the four pathways, <italic>prkcg</italic>, <italic>smad4</italic>, <italic>fzd2</italic>, <italic>ccne1</italic>, <italic>wnt5a</italic>, <italic>gli2</italic>, <italic>fzd8</italic>, <italic>axin1</italic>, <italic>ccna2</italic>, <italic>e2f3</italic>, <italic>plcb4</italic>, <italic>ctbp2</italic>, <italic>prkcb</italic>, <italic>porcn</italic>, <italic>ccnd2</italic>, <italic>plk1</italic>, <italic>ccne2</italic>, <italic>cdkn2b</italic>, <italic>ptch1</italic>, <italic>mcm6</italic>, <italic>lef1</italic>, <italic>ccnb1</italic>, <italic>osa</italic>, <italic>camk2a</italic>, <italic>ccnd1</italic>, <italic>ccnb2</italic>, <italic>cdkn1b</italic>, <italic>e2f1</italic>, <italic>lrp5</italic>, <italic>gli3</italic>, <italic>fzd9</italic>, <italic>smo</italic>, <italic>tcf7l2</italic>, <italic>camk2b</italic>, <italic>tfdp1</italic>, <italic>axin2</italic>, <italic>abl1</italic>, <italic>ctnnb1</italic>, and <italic>tcf3</italic> had significantly upregulated levels of gene expression as compared with healthy groups, while <italic>myc</italic>, <italic>gadd45b</italic>, <italic>cdkn1</italic>, <italic>gadd45g</italic>, <italic>mdm2</italic>, <italic>dvl3</italic>, <italic>bmp2</italic>, and <italic>ap-1</italic> were significantly downregulated, and there were some shared DEGs between these four pathways (FDR &lt; 0.05, FC &#x2265; 2) (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4F</bold>
</xref>). Details of these genes are listed in <xref ref-type="supplementary-material" rid="ST1">
<bold>Table S1</bold>
</xref>.</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>GSEA analysis of activated pathways and related genes that are associated with lymphocystis nodule formation after LCDV infection of flounder. <bold>(A)</bold> The number of activated pathways. <bold>(B-E)</bold> KEGG pathways associated with nodule formation including Wnt signaling pathway <bold>(B)</bold>, Hedgehog signaling pathway <bold>(C)</bold>, Cell cycle <bold>(D)</bold>, and Basal cell carcinoma <bold>(E)</bold>. <bold>(F)</bold> The heatmap of DEGs. GSEA was used to analyze the signaling pathway enrichment in different groups. Normalized enrichment score (NES) indicated the analysis results across gene sets. Nominal p-value presented if a set was significantly enriched.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-14-1268851-g004.tif"/>
</fig>
</sec>
<sec id="s3_5">
<label>3.5</label>
<title>Analysis of protein and KEGG pathway interaction networks</title>
<p>In order to identify the key genes, PPI analysis of the appeal genes showed that <italic>ctnnb1</italic>, <italic>ccnd1</italic>, <italic>lef1</italic>, <italic>ccnd2</italic>, and <italic>wnt5a</italic> played key roles as hub genes (<xref ref-type="fig" rid="f5">
<bold>Figures&#xa0;5A, B</bold>
</xref>), and details of the PPI were listed in <xref ref-type="supplementary-material" rid="ST2">
<bold>Table S2</bold>
</xref>. In addition to the four pathways in <xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4</bold>
</xref>, KEGG pathway enrichment analysis of PPI results revealed that pathways associated with nodule formation included Pathways in cancer and Viral carcinogenesis; pathways associated with viral infection included Human T-cell leukemia virus 1 infection, Human papillomavirus infection, Epstein-Barr virus infection, Kaposi sarcoma-associated herpesvirus infection, and Human cytomegalovirus infection; pathways associated with multiple cellular processes including p53 signaling pathway were also enriched (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5A</bold>
</xref>). The four pathways analyzed by GSEA (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4</bold>
</xref>) were subjected to KEGG pathway relationship analysis (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5C</bold>
</xref>), which indicated that the four pathways were associated with nodule formation included Gastric cancer, Hepatocellular carcinoma, Proteoglycans in cancer, Breast cancer, Endometrial cancer, and Colorectal cancer, pathways associated with multiple cellular processes included MAPK signaling pathway and TGF-beta signaling pathway in addition to the pathways analyzed in <xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5A</bold>
</xref>.</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>Interaction networks based on STRING analysis after LCDV infection of flounder. <bold>(A)</bold> Protein interaction network of up-regulated genes in <xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4F</bold>
</xref>. The table showed the KEGG analysis of the protein interaction network, dark blue was the pathway analyzed in <xref ref-type="fig" rid="f4">
<bold>Figures&#xa0;4B&#x2013;E</bold>
</xref>. <bold>(B)</bold> Node degrees of protein interaction network. <bold>(C)</bold> The KEGG database was used to construct the pathway network in <xref ref-type="fig" rid="f4">
<bold>Figures&#xa0;4B&#x2013;E</bold>
</xref>. The dotted line represented the presence of a relationship and the dot size represented the degree of connectivity.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-14-1268851-g005.tif"/>
</fig>
</sec>
<sec id="s3_6">
<label>3.6</label>
<title>GSEA analysis of differential gene expression profiles</title>
<p>In total, there were 27 down-regulated pathways (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6A</bold>
</xref>), of which the main ones associated with nodule formation included the cGMP-PKG signaling pathway (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6B</bold>
</xref>) and Calcium signaling pathway (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6C</bold>
</xref>) in Signal transduction; ECM-receptor interaction (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6D</bold>
</xref>) and Cytokine-cytokine receptor interaction (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6E</bold>
</xref>) in Signaling molecules and interactions. Genes, including <italic>prkcg</italic>, <italic>lamc3</italic>, <italic>col4a5</italic>, <italic>tnfsf12</italic>, <italic>col4a6</italic>, <italic>plcb4</italic>, <italic>xmrk</italic>, <italic>prkcb</italic>, <italic>tnfrsf19</italic>, <italic>csf1r2</italic>, <italic>lamb2</italic>, <italic>camk2a</italic>, <italic>ifnar2</italic>, <italic>tnfrsf1a</italic>, <italic>ptger1</italic>, <italic>gna11</italic>, <italic>adcy7</italic>, <italic>vdac2</italic>, <italic>plcg1</italic>, and <italic>camk2b</italic>, were all significantly upregulated, while <italic>f2r</italic>, <italic>egfr</italic>, <italic>il6r</italic>, <italic>pdgfra</italic>, <italic>rock2</italic>, <italic>col4a2</italic>, <italic>tgfbr2</italic>, <italic>ednrb</italic>, <italic>cxcl12</italic>, <italic>lama3</italic>, <italic>itga6</italic>, <italic>ll2rg</italic>, <italic>lamc2</italic>, <italic>csf1r1</italic>, <italic>gnai2</italic>, <italic>lamb3</italic>, <italic>agtr1</italic>, <italic>il13ra</italic>, <italic>pdgfrb</italic>, <italic>fn1</italic>, <italic>cxcr4</italic>, <italic>bdkrb2</italic>, <italic>ednra</italic>, <italic>bmp2</italic>, and <italic>adcy1</italic>, were all significantly downregulated (FDR &lt; 0.05, FC &#x2265; 2) (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6F</bold>
</xref>). Details of these genes are listed in <xref ref-type="supplementary-material" rid="ST1">
<bold>Table S1</bold>
</xref>.</p>
<fig id="f6" position="float">
<label>Figure&#xa0;6</label>
<caption>
<p>GSEA analysis of down-regulated pathways and related genes associated with nodule formation after LCDV infection of flounder. <bold>(A)</bold> The number of down-regulated pathways. <bold>(B-E)</bold> KEGG pathways associated with nodule formation including cGMP-PKG signaling pathway <bold>(B)</bold>, Calcium signaling pathway <bold>(C)</bold>, ECM-receptor interaction <bold>(D)</bold>, and Cytokine-cytokine receptor interaction <bold>(E)</bold>. <bold>(F)</bold> The heatmap of DEGs. GSEA was used to analyze the signaling pathways enrichment in different groups. Normalized enrichment score (NES) indicated the analysis results across gene sets. Nominal p-value presented if a set was significantly enriched.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-14-1268851-g006.tif"/>
</fig>
</sec>
<sec id="s3_7">
<label>3.7</label>
<title>Visualization of pathways in cancer</title>
<p>Enrichment of DEGs in <xref ref-type="fig" rid="f4">
<bold>Figures&#xa0;4F</bold>
</xref> and <xref ref-type="fig" rid="f6">
<bold>6F</bold>
</xref> into Pathways in cancer showed that these genes were involved in different signaling pathways, ultimately leading to cellular processes including Evading apoptosis and Proliferation, further suggesting that the pathways analyzed in <xref ref-type="fig" rid="f4">
<bold>Figures&#xa0;4</bold>
</xref> and <xref ref-type="fig" rid="f6">
<bold>6</bold>
</xref> synergistically promote nodule formation (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7A</bold>
</xref>).</p>
<fig id="f7" position="float">
<label>Figure&#xa0;7</label>
<caption>
<p>Pathways in cancer from KEGG. <bold>(A)</bold> Visualization of DEGs expression. Blue boxes represented pathways analyzed in <xref ref-type="fig" rid="f4">
<bold>Figures&#xa0;4B&#x2013;E</bold>
</xref> and <xref ref-type="fig" rid="f6">
<bold>6B&#x2013;E</bold>
</xref>; red boxes represented cellular effects; DEGs were filled in with color, with red representing up-regulation, green representing down-regulation and shades representing expression size. <bold>(B)</bold> The heatmap of DEGs.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-14-1268851-g007.tif"/>
</fig>
<p>In addition, the DEGs in Pathways in cancer were visualized and the heat map was analyzed. Among them, except for the DEGs analyzed in <xref ref-type="fig" rid="f4">
<bold>Figures&#xa0;4</bold>
</xref> and <xref ref-type="fig" rid="f6">
<bold>6</bold>
</xref>, <italic>fgf12</italic>, <italic>bcl-xl</italic>, <italic>bcl11a</italic>, <italic>pik3r2</italic>, <italic>traf2</italic>, <italic>fgfr1</italic>, <italic>fgf18</italic>, <italic>fgfr1a</italic>, <italic>araf</italic>, <italic>fgfr3</italic>, <italic>fgfr2</italic>, <italic>fgf14</italic>, <italic>pik3r1</italic>, <italic>elk3</italic>, <italic>crk</italic>, <italic>pik3r3</italic>, <italic>max</italic>, <italic>casp3</italic>, and <italic>bcl9</italic> were significantly upregulated (FDR &lt; 0.05, FC &#x2265; 2). In contrast, <italic>rasgrp2</italic>, <italic>phb2</italic>, <italic>fgf2</italic>, <italic>phb</italic>, <italic>rasgrp1</italic>, <italic>vegfb</italic>, <italic>kitlg</italic>, <italic>pik3ca</italic>, <italic>ets1</italic>, <italic>fos</italic>, <italic>vegfc</italic>, <italic>tchh</italic>, <italic>flt4</italic>, <italic>fgf16</italic>, <italic>rasgrp3</italic>, <italic>fgf6</italic>, <italic>cytc</italic>, <italic>hgf</italic>, <italic>epgn</italic>, <italic>fgf7</italic>, and <italic>fgf1</italic> were significantly downregulated (FDR &lt; 0.05, FC &#x2265; 2) (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7B</bold>
</xref>).</p>
</sec>
<sec id="s3_8">
<label>3.8</label>
<title>Tissue expression patterns of focused genes</title>
<p>The tissue expression patterns of several aforementioned key genes were examined by qRT-PCR, including ligand <italic>wnt5a</italic>, cell cycle-associated <italic>ccnd1</italic> and <italic>ccnd2</italic>, transcription factors <italic>ctnnb1</italic>, <italic>lef1</italic>, <italic>tcf3</italic>, and <italic>gli2</italic>, B-cell lymphoma/leukemia (BCL) family members <italic>bcl9</italic>, <italic>bcl11a</italic>, and <italic>bcl-xl</italic>, cytokine receptors <italic>fgfr1a</italic> and <italic>fgfr3</italic>. In comparison to the LCDV-uninfected group, <italic>wnt5a</italic> expression levels were considerably higher in the head kidney, trunk kidney, hindgut, gills, and skin (<italic>p</italic> &lt; 0.05). The cell cycle-related <italic>ccnd1</italic> and <italic>ccnd2</italic> all had significantly higher levels in the liver, head kidney, trunk kidney, and skin, and <italic>ccnd1</italic> was also significantly overexpressed in the gills (<italic>p</italic> &lt; 0.05). All transcription factors were significantly more highly expressed in liver and skin (<italic>p</italic> &lt; 0.05). In addition, <italic>ctnnb1</italic> and <italic>tcf3</italic> in the head kidney, <italic>ctnnb1</italic>, <italic>lef1</italic>, and <italic>gli2</italic> in the trunk kidney, <italic>lef1</italic> and <italic>gli2</italic> in the hindgut, and <italic>ctnnb1</italic>, <italic>tcf3</italic>, <italic>gli2</italic> in the gills were strongly expressed (<italic>p</italic> &lt; 0.05). BCL family members <italic>bcl9</italic>, <italic>bcl11a</italic>, and <italic>bcl-xl</italic> shared a similar expression pattern that all considerably overexpressed in liver, trunk kidney, gills, and skin (<italic>p</italic> &lt; 0.05). The cytokine receptors <italic>fgfr1a</italic> and <italic>fgfr3</italic> were all significantly highly expressed in the liver, spleen, trunk kidney, and skin, while <italic>fgfr3</italic> was also significantly overexpressed in the gills (<italic>p</italic> &lt; 0.05) (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8</bold>
</xref>).</p>
<fig id="f8" position="float">
<label>Figure&#xa0;8</label>
<caption>
<p>qRT-PCR of key genes of the focal pathway in various tissues of LCDV-infected flounder. The results were presented as the means &#xb1; SEM of four individuals. Asterisk indicated significant difference (<italic>p</italic> &lt; 0.05).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-14-1268851-g008.tif"/>
</fig>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<label>4</label>
<title>Discussion</title>
<p>The main target tissues for LCDV include the skin and fin where lymphocystis nodules usually develop. In recent searches, LCDV has been detected in internal organs such as brain, liver, kidney, spleen, and gut in addition to fins and skin (<xref ref-type="bibr" rid="B31">31</xref>&#x2013;<xref ref-type="bibr" rid="B33">33</xref>). According to several genetic studies, LCDV primarily affects the skin, gut, liver, and kidney (<xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B34">34</xref>&#x2013;<xref ref-type="bibr" rid="B36">36</xref>). In gilthead seabream (<italic>Sparus aurata</italic>), the LCDV genome has been detected in the caudal fin, gut, liver, spleen, kidney, and brain, with the highest viral loads in the caudal fin, followed by the kidney and brain (<xref ref-type="bibr" rid="B36">36</xref>). In <italic>Amphiprion ocellaris</italic>, LCDV is detected in the fin and spleen, while in Senegalese sole (<italic>Solea senegalensis</italic>), LCDV MCP gene transcripts are detected in the liver, kidney, brain, gut, and skin/fin at 5-7 dpi (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B34">34</xref>). Previously, we found that the target tissues of LCDV were skin, liver, spleen, kidney, gills, stomach, heart, and gut in flounder (<xref ref-type="bibr" rid="B37">37</xref>). In this study, obvious skin and fin nodules developed in flounder for about one month, and typical hypertrophic cells were present in skin nodules and LCDV particles were observed in the cytoplasm of these cells, while LCDV copy number detection showed the highest viral load in the skin, next in the gills, trunk kidney, hindgut, spleen and liver, and the lowest in the head kidney. Combining our previous study that showed flounder immunized with formalin-inactivated LCDV produced the most powerful immune responses at 21&#xb0;C in the spleen and head kidney (<xref ref-type="bibr" rid="B38">38</xref>), we suggested that the naturally infected flounder in this study had a long course of disease, strong immune responses in the spleen and head kidney might limit viral replication, whereas high viral loads remained in tissues with particularly pronounced foci, especially in the skin nodules. Moreover, studies on Senegalese sole (<italic>Solea senegalensis</italic>) and turbot (<italic>Scophthalmus maximus</italic>) have suggested that LCDV can spread to various tissues by infecting peripheral blood cells (<xref ref-type="bibr" rid="B34">34</xref>, <xref ref-type="bibr" rid="B39">39</xref>), and our study has found that LCDV can infect peripheral blood IgM<sup>+</sup> B cells that support viral replication through a 27.8kDa receptor-mediated mechanism (<xref ref-type="bibr" rid="B15">15</xref>), these results provide a rationalization for the detection of LCDV in all tissues of the flounder in this study.</p>
<p>The mechanism of lymphocystis cell formation in fish is less well studied. To date, significant alterations in genes related to cell cycle regulation have been found in flounder with lymphocystis cell formation by using microarray experiments, suggesting that LCDV infection leads to cell cycle arrest (<xref ref-type="bibr" rid="B5">5</xref>). In human prostate cancer cells, PHB and PHB2 have tumor suppressor functions, and they interact with the E2F transcription factor family in the nucleus to reduce E2F function, causing cell cycle arrest in the G1/S phase (<xref ref-type="bibr" rid="B40">40</xref>, <xref ref-type="bibr" rid="B41">41</xref>). In this study, transcriptome sequencing analysis of skin nodule tissue indicated that the cell cycle was activated with an up-regulation trend of cell cycle protein-related genes, differing from the significant down-regulation of <italic>phb</italic> and <italic>phb2</italic>, which might lead to rapid cell passage through the cycle checkpoint in favor of viral proliferation. Cell cycle is regulated by the upstream pathways, i.e., Wnt signaling pathway and Hedgehog signaling pathway, in which Wnt signaling pathway regulates various physiological processes such as growth control, stem cell renewal, embryonic development, and tissue differentiation (<xref ref-type="bibr" rid="B42">42</xref>). &#x3b2;-catenin (<italic>ctnnb1</italic>), the core transcription factor in Wnt signaling pathway, is normally located on the surface of the cell membrane, mostly involved in homotypic cell adhesion, and to a lesser extent in the cytoplasm, but it cannot enter the nucleus. Nevertheless, when mutations in &#x3b2;-catenin occur, &#x3b2;-catenin can accumulate in the cytoplasm and enter the nucleus where it binds to LEF/TCF to cause transcription of target genes, including the cell growth cycle-related genes <italic>ccnd1</italic> and <italic>ccnd2</italic>, causing pathological changes in cell growth, including tumor formation (<xref ref-type="bibr" rid="B43">43</xref>). In mammals, several viruses regulate &#x3b2;-catenin through their proteins to promote cell proliferation and tumorigenesis. As oncogenic viruses, KSHV using the LANA protein and EBV using LMP2A activate and stabilize &#x3b2;-catenin, allowing &#x3b2;-catenin to aggregate into the nucleus to regulate the upregulated expression of target genes including <italic>ccnd1</italic> and <italic>myc</italic>, ultimately leading to cell proliferation and even tumorigenesis (<xref ref-type="bibr" rid="B44">44</xref>, <xref ref-type="bibr" rid="B45">45</xref>). Similarly, HBV encodes HBx and hepatitis B surface antigen (HBsAg) proteins that silence antagonists of Wnt/&#x3b2;-catenin signaling pathway or upregulate and stabilize its key components, such as &#x3b2;-catenin, causing aberrant transcription of target genes, which drive cell proliferation and ultimately hepatocarcinogenesis (<xref ref-type="bibr" rid="B46">46</xref>). PHB can influence the role of WNT family members in cancer. For instance, overexpression of <italic>phb</italic> in human prostate cancer cells decreases the expression of several members of WNT family and reduces the motility and invasiveness of cancer cells, and <italic>phb</italic> plays an important role in the inter-regulation of <italic>wnt7b</italic>, <italic>wnt9a</italic>, and <italic>wnt10b</italic> with the cell cycle (<xref ref-type="bibr" rid="B40">40</xref>). In the present study, we found that Wnt signaling pathway was activated and the gene levels of <italic>ctnnb1</italic>, <italic>lef1</italic>, <italic>tcf3</italic>, <italic>ccnd1</italic>, and <italic>ccnd2</italic> were significantly upregulated, while <italic>ctnnb1</italic> was significantly co-expressed with <italic>ccnd1</italic> and <italic>ccnd2</italic> as hub genes in LCDV-infected skin, gills, head kidney, trunk kidney, and liver tissues. Wnt signaling pathway was also found to interact with multiple tumor pathways. These results suggested that LCDV activated Wnt signaling pathway as well as promoted cell proliferation and nodule formation by regulating <italic>ctnnb1</italic> which in turn leads to overexpression of cell cycle proteins. In addition, Wnt signaling pathway is reported to play an important role in the replication of several viruses. Activation of this pathway can promote avian leukosis virus subgroup J (ALV-J) gene expression and virus production in chicken embryonic fibroblasts cells, while inhibition of this pathway limits virus production in chicken embryonic fibroblasts cells and chicken hepatoma cells (<xref ref-type="bibr" rid="B47">47</xref>). Wnt/&#x3b2;-catenin signaling pathway is also thought to act in concert with the Bovine herpesvirus type1 latent gene product to maintain latent Bovine herpesvirus type1 infection, with &#x3b2;-catenin playing a central role (<xref ref-type="bibr" rid="B48">48</xref>). In this study, we also found that activated Wnt signaling pathway was associated with multiple viral infection pathways, including Human papillomavirus infection and Kaposi sarcoma-associated herpesvirus infection. These findings provided new insights into LCDV virus-host interaction and offered some potential antiviral strategies to control LCDV infection. However, the exact mechanism of which will require later in-depth studies.</p>
<p>The hedgehog signaling pathway was also activated in this study, and based on the KEGG database, we found that there was not only a reciprocal relationship between it and Wnt signaling pathway, but also a link to the tumor formation pathways. In this pathway, when the protein hedgehog (HH) ligand binds to the protein patched homolog (PTCH), smoothened homolog (SMO) repression is removed, and zinc-finger (ZF) transcription factor GLI activity is enhanced, which then enters the nucleus and activates transcription of genes that control cell proliferation, survival and differentiation (<xref ref-type="bibr" rid="B49">49</xref>, <xref ref-type="bibr" rid="B50">50</xref>). In this study, <italic>gli2</italic> and <italic>gli3</italic>, members of the GLI family, were significantly upregulated, and they could control cell cycle progression, regulate gene expression levels of cell cycle proteins including <italic>ccnd1</italic> and <italic>ccne2</italic>, and even promote tumourigenesis. It has been reported that silencing of <italic>gli2</italic> leads to cell cycle arrest in G0/G1 phase in human vascular smooth muscle cells and myofibroblasts (<xref ref-type="bibr" rid="B51">51</xref>, <xref ref-type="bibr" rid="B52">52</xref>). Similar studies in osteosarcoma, cervical cancer, hepatocellular carcinoma, and hepatocellular carcinogenesis have been conducted to control cell cycle progression (<xref ref-type="bibr" rid="B53">53</xref>&#x2013;<xref ref-type="bibr" rid="B56">56</xref>). In cervical cancer, <italic>gli2</italic> overexpression is found to promote cell proliferation, while knockdown of <italic>gli2</italic> causes a stalling effect in G0/G1 phase and a reduction in <italic>ccnd1</italic> gene expression and upregulation of <italic>p21</italic> and <italic>p27</italic> levels (<xref ref-type="bibr" rid="B54">54</xref>). In hepatocellular carcinoma, the knockdown of <italic>gli2</italic> gene results in G1 phase arrest, accompanied by downregulation of <italic>ccnd1</italic> and <italic>ccne2</italic> gene expression and upregulation of <italic>p21</italic> levels (<xref ref-type="bibr" rid="B55">55</xref>). Additionally, the oncogenic virus HBV is confirmed to contribute to hepatocellular carcinogenesis by regulating members of the GLI family, mainly due to the ability of HBx proteins to stabilize and activate the transcriptional activity of <italic>gli1</italic> and <italic>gli2</italic> (<xref ref-type="bibr" rid="B56">56</xref>). In osteosarcoma studies, silencing of <italic>gli2</italic> is found to cause upregulation of <italic>p21</italic>, inhibition of cyclin D1, SKP2, and phosphorylated Rb, thus inducing G1 phase arrest and ultimately preventing the growth of osteosarcoma (<xref ref-type="bibr" rid="B53">53</xref>). Basal cell carcinoma is one of the most common types of skin cancer, and Wnt signaling pathway and Hedgehog signaling pathway have been reported to play important roles in this cancer formation (<xref ref-type="bibr" rid="B57">57</xref>). Similarly, the present study analyzed a trend of up-regulation in Basal cell carcinoma, which shared the same DEGs with Wnt signaling pathway and Hedgehog signaling pathway, reinforcing the importance of the two pathways in lymphocystis nodule formation. Considering that <italic>gli2</italic> was expressed in a consistent pattern with <italic>ccnd1</italic> and <italic>ccnd2</italic> in skin, gill, trunk kidney, and liver tissues infected by LCDV in our study, we speculated that the Hedgehog signaling pathway might act in concert with Wnt signaling pathway to control the cell cycle and cause the formation of lymphocystis in fish.</p>
<p>Inhibition of apoptosis is thought to be a major factor in lymphocystis cell formation. By using microarray assay, the reference has investigated gene expression changes in the fins of LCDV-infected flounders and concluded that lymphocystis cell formation was mainly due to inhibition of apoptosis, including the down-regulation of caspase-3 precursor (<italic>casp3</italic>), caspase-6 precursor (<italic>casp6</italic>), caspase-8 precursor (<italic>casp8</italic>) and many other apoptosis-inducing genes (<xref ref-type="bibr" rid="B5">5</xref>). Unlike these results, <italic>casp3</italic> was found to be significantly up-regulated in the present study, while some members of the BCL family associated with cell proliferation and inhibition of apoptosis, including <italic>bcl9</italic>, <italic>bcl11a</italic>, and <italic>bcl-xl</italic>, were also considerably up-regulated in LCDV-infected skin, gill, trunk kidney, and liver tissues. BCL9/BCL9L binding to &#x3b2;-catenin can significantly affect tumor growth, suggesting that BCL9/BCL9L interacting with &#x3b2;-catenin plays a key role in tumor progression (<xref ref-type="bibr" rid="B58">58</xref>). Bcl11 gene family includes <italic>bcl11a</italic> and <italic>bcl11b</italic>, of which <italic>bcl11a</italic> is a proto-oncogene. In patients with Hodgkin lymphoma, <italic>bcl11a</italic> expression is found to be elevated and associated with EBV infection (<xref ref-type="bibr" rid="B59">59</xref>). Bcl-xl is an important member of the BCL-2 family and plays a crucial role in the inhibition of apoptosis (<xref ref-type="bibr" rid="B60">60</xref>). A study on HIV shows that &#x3b2;-catenin protects HIV-infected lymphocytes from apoptosis by directly activating the <italic>bcl-xl</italic> promoter activity to induce its expression (<xref ref-type="bibr" rid="B61">61</xref>). Therefore, up-regulation of <italic>bcl9</italic>, <italic>bcl11a</italic>, <italic>bcl-xl</italic>, and aforementioned <italic>ctnnb1</italic> in this study revealed that LCDV might regulate the BCL family through &#x3b2;-catenin to promote cell proliferation and inhibit apoptosis. Nevertheless, previous transcriptome analysis of flounder gills infected with LCDV indicates that genes associated with apoptosis including TNF ligand superfamily member 13B and TNF receptor-1 were up-regulated (<xref ref-type="bibr" rid="B6">6</xref>). Similarly, the present study found significant upregulation of <italic>tnfsf12</italic>, <italic>tnfrsf1a</italic>, and <italic>tnfrsf19</italic>, these genes might exert a pro-apoptotic effect which appeared to be detrimental to lymphocystis cell formation. But some studies have also found that LCDV can create cytoplasmic TNF receptor-like proteins after <italic>in vivo</italic> infection which react with multiple apoptotic or proliferative signaling proteins, thus inhibiting the apoptotic cascade downstream of the TNFR superfamily (<xref ref-type="bibr" rid="B62">62</xref>). In addition, the transcriptome results from flounder gills also demonstrate a downregulation of the apoptosis inhibitor <italic>bcl-2</italic> (<xref ref-type="bibr" rid="B6">6</xref>), which shows an opposite expression pattern to the BCL family members that inhibit apoptosis in this study. Combining these results, we suggested that skin cells infected by LCDV might initiate apoptosis to prevent the spread of the virus, while LCDV relied on its own proteins to interfere with apoptosis to facilitate proliferation, which was more like a competition between the virus and the host cells. VDAC2 was confirmed in our previous study to act as a functional receptor mediating the entry of LCDV into flounder gill (FG) cells (<xref ref-type="bibr" rid="B12">12</xref>). In the present study, <italic>vdac2</italic> was significantly upregulated, and we believe that it contributes to lymphocystis formation mainly because it also plays an important role in endogenous apoptosis. VDAC is responsible for the release of apoptosis-inducing proteins such as cytochrome C from the mitochondria into the cytoplasm to induce apoptosis, a process that is influenced by the competitive interactions of pro-apoptotic and anti-apoptotic factors with VDAC isoforms (<xref ref-type="bibr" rid="B63">63</xref>, <xref ref-type="bibr" rid="B64">64</xref>). The anti-apoptotic factors Bcl-2, Bcl-xL, or hexokinases block the binding of VDAC to pro-apoptotic proteins by interacting with VDAC to close the pore and thus prevent the release of cytochrome C (<xref ref-type="bibr" rid="B63">63</xref>). Additionally, at the gene level, we found that <italic>cytc</italic> was significantly down-regulated, suggesting that cytochrome C was inhibited at both the protein and gene levels thereby failing to exert its pro-apoptotic role. References have shown that effective pro-apoptotic factor bax-mediated apoptosis is dependent on vdac2 (<xref ref-type="bibr" rid="B65">65</xref>), whereas the anti-apoptotic factor bcl-xl exerts an anti-apoptotic effect by blocking bax damage to the outer mitochondrial membrane (<xref ref-type="bibr" rid="B66">66</xref>). Moreover, LCDV produces the TNF receptor analog and VDAC can be oligomerized by TNF-&#x3b1;, which may contribute to the inhibition of apoptosis by LCDV (<xref ref-type="bibr" rid="B3">3</xref>). VDAC can interact with viral proteins to reduce apoptosis in infected cells, as shown in Infectious Bursal Disease Virus whose VP5 formed a complex with RACK1 and VDAC2 to inhibit apoptosis (<xref ref-type="bibr" rid="B67">67</xref>). RACK1 is also a receptor for LCDV entry into FG cells together with VDAC2, and not only that, the gene expression levels of RACK1 reach a peak later than VDAC2 after LCDV infection (<xref ref-type="bibr" rid="B12">12</xref>). In this study, RACK1 showed an up-regulation trend although it was not significant (<xref ref-type="supplementary-material" rid="ST1">
<bold>Table S1</bold>
</xref>), this might due to the difference in the expression time of the two receptors. Therefore, RACK1 as a receptor for LCDV entry might also play a role in lymphocystis formation. However, whether LCDV proteins forming a complex with VDAC2/RACK1 can inhibit host cell apoptosis, and whether VDAC2/RACK1 determines the balance between cell death and survival (that is, apoptosis and lymphocystis cell formation), need to be further investigated.</p>
<p>Fibroblast growth factors (FGFs) bind to their receptors, fibroblast growth factor receptors (FGFRs), and activate the downstream signaling pathways they regulate, playing an important role in both pro-mitotic (embryogenesis, growth, and development) and non-mitotic (neuromodulation, metabolic regulation) biological processes. Among these pathways, high expression and mutations of fgfr lead to abnormal activation of the signaling pathway, resulting in uncontrolled pro-division and subsequent tumor production (<xref ref-type="bibr" rid="B68">68</xref>), for example, significant expression of <italic>fgfr2</italic> has been detected in cervical cancer (<xref ref-type="bibr" rid="B69">69</xref>). In addition, it is shown that the addition of the pan FGFR inhibitor AZD4547 alone inhibits the growth of cells associated with E2/E4/E5 in HPV positive tumor (<xref ref-type="bibr" rid="B70">70</xref>). In the present study, the FGFR family members, <italic>fgfr1</italic>, <italic>fgfr2</italic>, and <italic>fgfr3</italic>, were significantly upregulated in the skin nodule tissue of LCDV-infected flounder. <italic>Fgfr3</italic> is the first member of the FGFR family, which undergoes somatic mutations in tumors and is expressed at elevated levels in cell lines through repeated translocations to and from immunoglobulin heavy chain (IGH) sites (<xref ref-type="bibr" rid="B71">71</xref>, <xref ref-type="bibr" rid="B72">72</xref>). <italic>Fgfr1</italic> is thought to be similar to <italic>fgfr3</italic> in recurrent translocations in some tumors (<xref ref-type="bibr" rid="B73">73</xref>), but little functional validation has been reported except that it promotes tumorigenesis through gene amplification and overexpression (<xref ref-type="bibr" rid="B74">74</xref>). FGFRs also play a role in viral infection, and fgfr1 acts as a co-receptor for adeno-associated virus type 3 (AAV-3) strain H (<xref ref-type="bibr" rid="B75">75</xref>). So, it is reasonable to infer that FGFRs might play a similar role in lymphocystis formation after LCDV infection, but more evidence is required to clarify this.</p>
<p>The P53 signaling pathway is involved in several cellular processes and is particularly important in suppressing tumor formation. Several oncogenic viruses promote tumor formation by modulating the p53 signaling pathway. For example, HBV inhibits p53-induced apoptosis by suppressing p53 activity through its HBx protein (<xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B76">76</xref>). HCV affects the DNA-binding function of p53 through its NS5A protein (<xref ref-type="bibr" rid="B17">17</xref>). While HPV E6/E7 proteins and MCPyV tumor antigen inhibit and degrade p53 and affect other pathways closely associated with cancer including the Notch signaling pathway and TGF-beta signaling pathway (<xref ref-type="bibr" rid="B77">77</xref>&#x2013;<xref ref-type="bibr" rid="B80">80</xref>). In addition, oncogenic viruses often manipulate the MAPK signaling pathway to promote host cell proliferation and cause cell metastasis. EBV activates the MAPK signaling pathway through the LMP1 protein to contribute to nasopharyngeal carcinoma cell invasion (<xref ref-type="bibr" rid="B81">81</xref>). KSHV activates the MK2 kinase, an effector of the MAPK signaling pathway, through the kaposin B protein to promote tumor formation (<xref ref-type="bibr" rid="B82">82</xref>). In this study, although there was no significant trend of up- and down-regulation of the p53 signaling pathway, TGF-beta signaling pathway, and MAPK signaling pathway, we found that there was a linkage of these pathways with Wnt signaling pathway and Cell cycle, implying that there were common DEGs of these pathways that promoted the formation of lymphocystis cells.</p>
<p>In summary, we performed RNA-seq on skin nodule tissues of naturally LCDV-infected flounder using high-throughput sequencing technology and analyzed transcriptome data, and found that Wnt signaling pathway, Hedgehog signaling pathway, Cell cycle, and Basal cell carcinoma associated with lymphocystis formation were activated. These pathways regulated cell cycle-related genes such as <italic>ccnd1</italic> and <italic>ccnd2</italic> through key genes such as <italic>ctnnb1</italic> and <italic>gli2</italic> to promote cell proliferation, which has been shown to interact with several viral infection and tumor formation pathways, and therefore they are considered to be an important cause of lymphocystis formation. <italic>Bcl9</italic>, <italic>bcl11a</italic>, and <italic>bcl-xl</italic>, members of the BCL family that promote cell proliferation and inhibit apoptosis, were significantly upregulated, as were <italic>fgfr1</italic>, <italic>fgfr2</italic>, and <italic>fgfr3</italic>, which are closely related to tumor formation. <italic>Tnfsf12</italic>, <italic>tnfrsf1a</italic>, and <italic>tnfrsf19</italic>, which are associated with pro-apoptosis, as well as <italic>vdac2</italic>, which promotes viral replication by inhibiting apoptosis, also acts as a receptor for LCDV entry, were significantly upregulated. Pro-apoptotic <italic>cytc</italic> and anti-tumor <italic>phb</italic> and <italic>phb2</italic> were significantly down-regulated. These results are expected to explain the molecular basis of lymphocystis formation after LCDV infection of flounder. For the first time, we have analyzed the pathways and differentially expressed genes associated with lymphocystis formation using high-throughput sequencing technology, providing a new breakthrough in the study of lymphocystis formation in fish.</p>
</sec>
<sec id="s5" sec-type="data-availability">
<title>Data availability statement</title>
<p>The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found below: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/">https://www.ncbi.nlm.nih.gov/</ext-link>, SAMN36345915; <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/">https://www.ncbi.nlm.nih.gov/</ext-link>, SAMN36345916; <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/">https://www.ncbi.nlm.nih.gov/</ext-link>, SAMN36345917; <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/">https://www.ncbi.nlm.nih.gov/</ext-link>, SAMN36345918; <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/">https://www.ncbi.nlm.nih.gov/</ext-link>, SAMN36345919; <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/">https://www.ncbi.nlm.nih.gov/</ext-link>, SAMN36345920; <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/">https://www.ncbi.nlm.nih.gov/</ext-link>, SAMN36345921; <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/">https://www.ncbi.nlm.nih.gov/</ext-link>, SAMN36345922.</p>
</sec>
<sec id="s6" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>The animal study was approved by the Animal Care and Use Committee of Ocean University of China (permit number: OUC-AE-2022-071). The study was conducted in accordance with the local legislation and institutional requirements.</p>
</sec>
<sec id="s7" sec-type="author-contributions">
<title>Author contributions</title>
<p>HZ: Data curation, Formal Analysis, Investigation, Writing &#x2013; original draft, Methodology, Validation. XS: Conceptualization, Formal Analysis, Funding acquisition, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing, Project administration. XT: Formal Analysis, Resources, Writing &#x2013; review &amp; editing, Methodology, Validation. JX: Formal Analysis, Writing &#x2013; review &amp; editing, Resources, Validation. HC: Formal Analysis, Resources, Writing &#x2013; review &amp; editing, Validation. WZ: Conceptualization, Funding acquisition, Writing &#x2013; review &amp; editing, Supervision.</p>
</sec>
</body>
<back>
<sec id="s8" sec-type="funding-information">
<title>Funding</title>
<p>The authors declare financial support was received for the research, authorship, and/or publication of this article. This study was supported by the National Natural Science Foundation of China (Grant numbers: 32273163, 31872599, and 31730101).</p>
</sec>
<sec id="s9" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
<p>The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.</p>
</sec>
<sec id="s10" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors&#xa0;and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s11" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fimmu.2023.1268851/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fimmu.2023.1268851/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Table_1.xlsx" id="ST1" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet"/>
<supplementary-material xlink:href="Table_2.xlsx" id="ST2" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leiva-Rebollo</surname> <given-names>R</given-names>
</name>
<name>
<surname>G&#xe9;mez-Mata</surname> <given-names>J</given-names>
</name>
<name>
<surname>Castro</surname> <given-names>D</given-names>
</name>
<name>
<surname>Borrego</surname> <given-names>JJ</given-names>
</name>
<name>
<surname>Labella</surname> <given-names>AM</given-names>
</name>
</person-group>. <article-title>Immune response of DNA vaccinated-gilthead seabream (<italic>Sparus aurata</italic>) against LCDV-Sa infection: relevance of the inflammatory process</article-title>. <source>Front Immunol</source> (<year>2023</year>) <volume>14</volume>:<elocation-id>1209926</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2023.1209926</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cheng</surname> <given-names>SF</given-names>
</name>
<name>
<surname>Zhan</surname> <given-names>WB</given-names>
</name>
<name>
<surname>Xing</surname> <given-names>J</given-names>
</name>
<name>
<surname>Sheng</surname> <given-names>XZ</given-names>
</name>
</person-group>. <article-title>Development and characterization of monoclonal antibody to the lymphocystis disease virus of Japanese flounder <italic>Paralichthys olivaceus</italic> isolated from China</article-title>. <source>J Virol Methods</source> (<year>2006</year>) <volume>135</volume>:<page-range>173&#x2013;80</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jviromet.2006.03.016</pub-id>
</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pontejo</surname> <given-names>SM</given-names>
</name>
<name>
<surname>S&#xe1;nchez</surname> <given-names>C</given-names>
</name>
<name>
<surname>Mart&#xed;n</surname> <given-names>R</given-names>
</name>
<name>
<surname>Mulero</surname> <given-names>V</given-names>
</name>
<name>
<surname>Alcami</surname> <given-names>A</given-names>
</name>
<name>
<surname>Alejo</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>An orphan viral TNF receptor superfamily member identified in lymphocystis disease virus</article-title>. <source>Virol J</source> (<year>2013</year>) <volume>10</volume>:<elocation-id>188</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/1743-422X-10-188</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ross</surname> <given-names>N</given-names>
</name>
<name>
<surname>Ruggieri</surname> <given-names>GD</given-names>
</name>
</person-group>. <article-title>Studies on virus diseases of fishes, spontaneous and experimentally induced cellular hypertrophy (lymphocystis disease) in fishes of the New York aquarium, with a report of new cases and an annotated bibliography (1874&#x2013;1965)</article-title>. <source>Deep-Sea Res Oceanogr Abstr</source> (<year>1965</year>) <volume>50</volume>:<fpage>83</fpage>&#x2013;<lpage>95</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/0011-7471(76)91096-2</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iwakiri</surname> <given-names>S</given-names>
</name>
<name>
<surname>Song</surname> <given-names>JY</given-names>
</name>
<name>
<surname>Nakayama</surname> <given-names>K</given-names>
</name>
<name>
<surname>Oh</surname> <given-names>MJ</given-names>
</name>
<name>
<surname>Ishida</surname> <given-names>M</given-names>
</name>
<name>
<surname>Kitamura</surname> <given-names>SI</given-names>
</name>
</person-group>. <article-title>Host responses of Japanese flounder <italic>Paralichthys olivaceus</italic> with lymphocystis cell formation</article-title>. <source>Fish Shellfish Immunol</source> (<year>2014</year>) <volume>38</volume>:<page-range>406&#x2013;11</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.fsi.2014.03.028</pub-id>
</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname> <given-names>RH</given-names>
</name>
<name>
<surname>Sheng</surname> <given-names>XZ</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>XQ</given-names>
</name>
<name>
<surname>Xing</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zhan</surname> <given-names>WB</given-names>
</name>
</person-group>. <article-title>Transcriptome Analysis of Flounder (<italic>Paralichthys olivaceus</italic>) Gill in Response to Lymphocystis Disease Virus (LCDV) Infection: Novel Insights into Fish Defense Mechanisms</article-title>. <source>Int J Mol Sci</source> (<year>2018</year>) <volume>19</volume>:<elocation-id>160</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms19010160</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>L&#xf3;pez-Bueno</surname> <given-names>A</given-names>
</name>
<name>
<surname>Mavian</surname> <given-names>C</given-names>
</name>
<name>
<surname>Labella</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Castro</surname> <given-names>D</given-names>
</name>
<name>
<surname>Borrego</surname> <given-names>JJ</given-names>
</name>
<name>
<surname>Alcami</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Concurrence of iridovirus, polyomavirus, and a unique member of a new group of fish papillomaviruses in lymphocystis disease-affected gilthead sea bream</article-title>. <source>J Virol</source> (<year>2016</year>) <volume>90</volume>:<page-range>8768&#x2013;79</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/JVI.01369-16</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cheng</surname> <given-names>MC</given-names>
</name>
<name>
<surname>See</surname> <given-names>MS</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>PC</given-names>
</name>
<name>
<surname>Kuo</surname> <given-names>YT</given-names>
</name>
<name>
<surname>Ho</surname> <given-names>YS</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>SC</given-names>
</name>
<etal/>
</person-group>. <article-title>Lymphocystis disease virus infection in clownfish <italic>Amphiprion ocellaris</italic> and <italic>Amphiprion clarkii</italic> in Taiwan</article-title>. <source>Animals</source> (<year>2022</year>) <volume>13</volume>:<elocation-id>153</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ani13010153</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sheng</surname> <given-names>XZ</given-names>
</name>
<name>
<surname>Zhong</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zeng</surname> <given-names>J</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>XQ</given-names>
</name>
<name>
<surname>Xing</surname> <given-names>J</given-names>
</name>
<name>
<surname>Chi</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Lymphocystis disease virus (<italic>Iridoviridae</italic>) enters flounder (<italic>Paralichthys olivaceus</italic>) gill cells via a caveolae-mediated endocytosis mechanism facilitated by viral receptors</article-title>. <source>Int J Mol Sci</source> (<year>2020</year>) <volume>21</volume>:<elocation-id>4722</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms21134722</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname> <given-names>RH</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>XQ</given-names>
</name>
<name>
<surname>Sheng</surname> <given-names>XZ</given-names>
</name>
<name>
<surname>Zhan</surname> <given-names>WB</given-names>
</name>
</person-group>. <article-title>Relationship between expression of cellular receptor-27.8kDa and lymphocystis disease virus (LCDV) infection</article-title>. <source>PloS One</source> (<year>2015</year>) <volume>10</volume>:<elocation-id>e0127940</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0127940</pub-id>
</citation>
</ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhong</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Fei</surname> <given-names>CJ</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>XQ</given-names>
</name>
<name>
<surname>Zhan</surname> <given-names>WB</given-names>
</name>
<name>
<surname>Sheng</surname> <given-names>XZ</given-names>
</name>
</person-group>. <article-title>A 32 kDa viral attachment protein of lymphocystis disease virus (LCDV) specifically interacts with a 27.8 kDa cellular receptor from flounder (<italic>Paralichthys olivaceus</italic>)</article-title>. <source>J Gen Virol</source> (<year>2017</year>) <volume>98</volume>:<page-range>1477&#x2013;88</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1099/jgv.0.000805</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhong</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>XQ</given-names>
</name>
<name>
<surname>Sheng</surname> <given-names>XZ</given-names>
</name>
<name>
<surname>Xing</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zhan</surname> <given-names>WB</given-names>
</name>
</person-group>. <article-title>Voltage-dependent anion channel protein 2 (VDAC2) and receptor of activated protein c kinase 1 (RACK1) act as functional receptors for lymphocystis disease virus infection</article-title>. <source>J Virol</source> (<year>2019</year>) <volume>93</volume>:<page-range>e00122&#x2013;19</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/JVI.00122-19</pub-id>
</citation>
</ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garc&#xed;a-Rosado</surname> <given-names>E</given-names>
</name>
</person-group>. <article-title>Serological techniques for detection of lymphocystis virus in fish</article-title>. <source>Aquat Living Resour</source> (<year>2002</year>) <volume>15</volume>:<page-range>179&#x2013;85</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0990-7440(02)01174-9</pub-id>
</citation>
</ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cano</surname> <given-names>I</given-names>
</name>
<name>
<surname>Ferro</surname> <given-names>P</given-names>
</name>
<name>
<surname>Alonso</surname> <given-names>MC</given-names>
</name>
<name>
<surname>Sarasquete</surname> <given-names>C</given-names>
</name>
<name>
<surname>Garcia-Rosado</surname> <given-names>E</given-names>
</name>
<name>
<surname>Borrego</surname> <given-names>JJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Application of in <italic>situ</italic> detection techniques to determine the systemic condition of lymphocystis disease virus infection in cultured gilt-head seabream, <italic>Sparus aurata</italic> L</article-title>. <source>J Fish Dis</source> (<year>2009</year>) <volume>32</volume>:<page-range>143&#x2013;50</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1365-2761.2008.00970.x</pub-id>
</citation>
</ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sheng</surname> <given-names>XZ</given-names>
</name>
<name>
<surname>Zeng</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zhong</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>XQ</given-names>
</name>
<name>
<surname>Xing</surname> <given-names>J</given-names>
</name>
<name>
<surname>Chi</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Peripheral blood B-lymphocytes are involved in lymphocystis disease virus infection in flounder (<italic>Paralichthys olivaceus</italic>) via cellular receptor-mediated mechanism</article-title>. <source>Int J Mol Sci</source> (<year>2022</year>) <volume>23</volume>:<elocation-id>9225</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms23169225</pub-id>
</citation>
</ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moore</surname> <given-names>PS</given-names>
</name>
<name>
<surname>Chang</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>Why do viruses cause cancer? Highlights of the first century of human tumour virology</article-title>. <source>Nat Rev Cancer</source> (<year>2010</year>) <volume>10</volume>:<page-range>878&#x2013;89</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nrc2961</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Akram</surname> <given-names>N</given-names>
</name>
<name>
<surname>Imran</surname> <given-names>M</given-names>
</name>
<name>
<surname>Noreen</surname> <given-names>M</given-names>
</name>
<name>
<surname>Ahmed</surname> <given-names>F</given-names>
</name>
<name>
<surname>Atif</surname> <given-names>M</given-names>
</name>
<name>
<surname>Fatima</surname> <given-names>Z</given-names>
</name>
<etal/>
</person-group>. <article-title>Oncogenic role of tumor viruses in humans</article-title>. <source>Viral Immunol</source> (<year>2017</year>) <volume>30</volume>:<page-range>20&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1089/vim.2016.0109</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Gerstein</surname> <given-names>M</given-names>
</name>
<name>
<surname>Snyder</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>RNA-Seq: a revolutionary tool for transcriptomics</article-title>. <source>Nat Rev Genet</source> (<year>2009</year>) <volume>10</volume>:<fpage>57</fpage>&#x2013;<lpage>63</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nrg2484</pub-id>
</citation>
</ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kozarewa</surname> <given-names>I</given-names>
</name>
<name>
<surname>Ning</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Quail</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Sanders</surname> <given-names>MJ</given-names>
</name>
<name>
<surname>Berriman</surname> <given-names>M</given-names>
</name>
<name>
<surname>Turner</surname> <given-names>DJ</given-names>
</name>
</person-group>. <article-title>Amplification-free Illumina sequencing-library preparation facilitates improved mapping and assembly of (G+C)-biased genomes</article-title>. <source>Nat Methods</source> (<year>2009</year>) <volume>6</volume>:<page-range>291&#x2013;5</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nmeth.1311</pub-id>
</citation>
</ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martin</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Z</given-names>
</name>
</person-group>. <article-title>Next-generation transcriptome assembly</article-title>. <source>Nat Rev Genet</source> (<year>2011</year>) <volume>12</volume>:<page-range>671&#x2013;82</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nrg3068</pub-id>
</citation>
</ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhong</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>XQ</given-names>
</name>
<name>
<surname>Sheng</surname> <given-names>XZ</given-names>
</name>
<name>
<surname>Xing</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zhan</surname> <given-names>WB</given-names>
</name>
</person-group>. <article-title>Development and characterization of monoclonal antibodies to the 32 kDa viral attachment protein of lymphocystis disease virus and their neutralizing ability <italic>in vitro</italic>
</article-title>. <source>Int J Mol Sci</source> (<year>2018</year>) <volume>19</volume>:<elocation-id>2536</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms19092536</pub-id>
</citation>
</ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>SF</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>YQ</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>YR</given-names>
</name>
<name>
<surname>Gu</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>fastp: an ultra-fast all-in-one FASTQ preprocessor</article-title>. <source>Bioinformatics</source> (<year>2018</year>) <volume>34</volume>:<page-range>i884&#x2013;90</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/bioinformatics/bty560</pub-id>
</citation>
</ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Langmead</surname> <given-names>B</given-names>
</name>
<name>
<surname>Salzberg</surname> <given-names>SL</given-names>
</name>
</person-group>. <article-title>Fast gapped-read alignment with Bowtie 2</article-title>. <source>Nat Methods</source> (<year>2012</year>) <volume>9</volume>:<page-range>357&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nmeth.1923</pub-id>
</citation>
</ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname> <given-names>D</given-names>
</name>
<name>
<surname>Langmead</surname> <given-names>B</given-names>
</name>
<name>
<surname>Salzberg</surname> <given-names>SL</given-names>
</name>
</person-group>. <article-title>HISAT: a fast spliced aligner with low memory requirements</article-title>. <source>Nat Methods</source> (<year>2015</year>) <volume>12</volume>:<page-range>357&#x2013;60</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nmeth.3317</pub-id>
</citation>
</ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Love</surname> <given-names>MI</given-names>
</name>
<name>
<surname>Huber</surname> <given-names>W</given-names>
</name>
<name>
<surname>Anders</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title>. <source>Genome Biol</source> (<year>2014</year>) <volume>15</volume>:<elocation-id>550</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id>
</citation>
</ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Subramanian</surname> <given-names>A</given-names>
</name>
<name>
<surname>Tamayo</surname> <given-names>P</given-names>
</name>
<name>
<surname>Mootha</surname> <given-names>VK</given-names>
</name>
<name>
<surname>Mukherjee</surname> <given-names>S</given-names>
</name>
<name>
<surname>Ebert</surname> <given-names>BL</given-names>
</name>
<name>
<surname>Gillette</surname> <given-names>MA</given-names>
</name>
<etal/>
</person-group>. <article-title>Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles</article-title>. <source>Proc Natl Acad Sci U.S.A</source> (<year>2005</year>) <volume>102</volume>:<page-range>15545&#x2013;50</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.0506580102</pub-id>
</citation>
</ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Auwera</surname> <given-names>GA</given-names>
</name>
<name>
<surname>Carneiro</surname> <given-names>MO</given-names>
</name>
<name>
<surname>Hartl</surname> <given-names>C</given-names>
</name>
<name>
<surname>Poplin</surname> <given-names>R</given-names>
</name>
<name>
<surname>del Angel</surname> <given-names>G</given-names>
</name>
<name>
<surname>Levy-Moonshine</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>From FastQ data to high-confidence variant calls: the genome analysis toolkit best practices pipeline</article-title>. <source>Curr Protoc Bioinf</source> (<year>2013</year>) <volume>43</volume>(<issue>1110</issue>):<page-range>11.10.1&#x2013;11.10.33</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/0471250953.bi1110s43</pub-id>
</citation>
</ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Szklarczyk</surname> <given-names>D</given-names>
</name>
<name>
<surname>Franceschini</surname> <given-names>A</given-names>
</name>
<name>
<surname>Wyder</surname> <given-names>S</given-names>
</name>
<name>
<surname>Forslund</surname> <given-names>K</given-names>
</name>
<name>
<surname>Heller</surname> <given-names>D</given-names>
</name>
<name>
<surname>Huerta-Cepas</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>STRING v10: protein&#x2013;protein interaction networks, integrated over the tree of life</article-title>. <source>Nucleic Acids Res</source> (<year>2015</year>) <volume>43</volume>:<page-range>D447&#x2013;52</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/nar/gku1003</pub-id>
</citation>
</ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luo</surname> <given-names>WJ</given-names>
</name>
<name>
<surname>Pant</surname> <given-names>G</given-names>
</name>
<name>
<surname>Bhavnasi</surname> <given-names>YK</given-names>
</name>
<name>
<surname>Blanchard</surname> <given-names>SG</given-names>
</name>
<name>
<surname>Brouwer</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>Pathview Web: user friendly pathway visualization and data integration</article-title>. <source>Nucleic Acids Res</source> (<year>2017</year>) <volume>45</volume>:<page-range>W501&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/nar/gkx372</pub-id>
</citation>
</ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luo</surname> <given-names>WJ</given-names>
</name>
<name>
<surname>Brouwer</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>Pathview: an R/Bioconductor package for pathway-based data integration and visualization</article-title>. <source>Bioinformatics</source> (<year>2013</year>) <volume>29</volume>:<page-range>1830&#x2013;1</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/bioinformatics/btt285</pub-id>
</citation>
</ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rahmati-Holasoo</surname> <given-names>H</given-names>
</name>
<name>
<surname>Ahmadivand</surname> <given-names>S</given-names>
</name>
<name>
<surname>Marandi</surname> <given-names>A</given-names>
</name>
<name>
<surname>Shokrpoor</surname> <given-names>S</given-names>
</name>
<name>
<surname>Pali&#x107;</surname> <given-names>D</given-names>
</name>
<name>
<surname>Jahangard</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Identification and characterization of lymphocystis disease virus (LCDV) from Indian glassy fish (<italic>Parambassis ranga Hamilton</italic>, 1822) in Iran</article-title>. <source>Aquacult Int</source> (<year>2022</year>) <volume>30</volume>:<page-range>2593&#x2013;602</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s10499-022-00922-7</pub-id>
</citation>
</ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rahmati-Holasoo</surname> <given-names>H</given-names>
</name>
<name>
<surname>Ghalyanchilangeroudi</surname> <given-names>A</given-names>
</name>
<name>
<surname>Ziafati Kafi</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Marandi</surname> <given-names>A</given-names>
</name>
<name>
<surname>Shokrpoor</surname> <given-names>S</given-names>
</name>
<name>
<surname>Imantalab</surname> <given-names>B</given-names>
</name>
<etal/>
</person-group>. <article-title>Detection of lymphocystis disease virus (LCDV) from yellowbar angelfish (<italic>Pomacanthus maculosus</italic> Forssk&#xe5;l, 1775) in Iran: Histopathological and phylogenetic analysis</article-title>. <source>Aquaculture</source> (<year>2023</year>) <volume>562</volume>:<elocation-id>738862</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.aquaculture.2022.738862</pub-id>
</citation>
</ref>
<ref id="B33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kvitt</surname> <given-names>H</given-names>
</name>
<name>
<surname>Heinisch</surname> <given-names>G</given-names>
</name>
<name>
<surname>Diamant</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Detection and phylogeny of <italic>Lymphocystivirus</italic> in sea bream <italic>Sparus aurata</italic> based on the DNA polymerase gene and major capsid protein sequences</article-title>. <source>Aquaculture</source> (<year>2008</year>) <volume>275</volume>:<fpage>58</fpage>&#x2013;<lpage>63</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.aquaculture.2008.01.007</pub-id>
</citation>
</ref>
<ref id="B34">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carballo</surname> <given-names>C</given-names>
</name>
<name>
<surname>Castro</surname> <given-names>D</given-names>
</name>
<name>
<surname>Borrego</surname> <given-names>JJ</given-names>
</name>
<name>
<surname>ManChado</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Gene expression profiles associated with lymphocystis disease virus (LCDV) in experimentally infected Senegalese sole (<italic>Solea Senegalensis</italic>)</article-title>. <source>Fish Shellfish Immunol</source> (<year>2017</year>) <volume>66</volume>:<page-range>129&#x2013;39</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.fsi.2017.04.028</pub-id>
</citation>
</ref>
<ref id="B35">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname> <given-names>GB</given-names>
</name>
<name>
<surname>Lou</surname> <given-names>HM</given-names>
</name>
<name>
<surname>Dong</surname> <given-names>XZ</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>QM</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>SC</given-names>
</name>
</person-group>. <article-title>Characteristics of the interferon regulatory factor 5 (IRF5) and its expression in response to LCDV and poly I:C challenges in Japanese flounder, <italic>Paralichthys olivaceus</italic>
</article-title>. <source>Dev Comp Immunol</source> (<year>2012</year>) <volume>38</volume>:<page-range>377&#x2013;82</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.dci.2012.06.001</pub-id>
</citation>
</ref>
<ref id="B36">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Valverde</surname> <given-names>EJ</given-names>
</name>
<name>
<surname>Borrego</surname> <given-names>JJ</given-names>
</name>
<name>
<surname>Sarasquete</surname> <given-names>MC</given-names>
</name>
<name>
<surname>Ortiz-Delgado</surname> <given-names>JB</given-names>
</name>
<name>
<surname>Castro</surname> <given-names>D</given-names>
</name>
</person-group>. <article-title>Target organs for lymphocystis disease virus replication in gilthead seabream (<italic>Sparus aurata</italic>)</article-title>. <source>Vet Res</source> (<year>2017</year>) <volume>48</volume>:<fpage>21</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13567-017-0428-3</pub-id>
</citation>
</ref>
<ref id="B37">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhan</surname> <given-names>WB</given-names>
</name>
<name>
<surname>Li</surname> <given-names>YQ</given-names>
</name>
<name>
<surname>Sheng</surname> <given-names>XZ</given-names>
</name>
<name>
<surname>Xing</surname> <given-names>J</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>XQ</given-names>
</name>
</person-group>. <article-title>Detection of lymphocystis disease virus in Japanese flounder <italic>Paralichthys olivaceus</italic> and other marine teleosts from northern China</article-title>. <source>Chin J Ocean Limnol</source> (<year>2010</year>) <volume>28</volume>:<page-range>1213&#x2013;20</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00343-010-9934-0</pub-id>
</citation>
</ref>
<ref id="B38">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname> <given-names>GJ</given-names>
</name>
<name>
<surname>Sheng</surname> <given-names>XZ</given-names>
</name>
<name>
<surname>Xing</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zhan</surname> <given-names>WB</given-names>
</name>
</person-group>. <article-title>Effect of temperature on immune response of Japanese flounder (<italic>Paralichthys olivaceus</italic>) to inactivated lymphocystis disease virus (LCDV)</article-title>. <source>Fish Shellfish Immunol</source> (<year>2011</year>) <volume>30</volume>:<page-range>525&#x2013;31</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.fsi.2010.11.026</pub-id>
</citation>
</ref>
<ref id="B39">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sheng</surname> <given-names>XZ</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>RH</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>XQ</given-names>
</name>
<name>
<surname>Xing</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zhan</surname> <given-names>WB</given-names>
</name>
</person-group>. <article-title>Tissue localization of lymphocystis disease virus (LCDV) receptor-27.8 kDa and its expression kinetics induced by the viral infection in turbot (<italic>Scophthalmus maximus</italic>)</article-title>. <source>Int J Mol Sci</source> (<year>2015</year>) <volume>16</volume>:<page-range>26506&#x2013;19</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms161125974</pub-id>
</citation>
</ref>
<ref id="B40">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koushyar</surname> <given-names>S</given-names>
</name>
<name>
<surname>Uysal-Onganer</surname> <given-names>P</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>WG</given-names>
</name>
<name>
<surname>Dart</surname> <given-names>DA</given-names>
</name>
</person-group>. <article-title>Prohibitin links cell cycle, motility and invasion in prostate cancer cells</article-title>. <source>Int J Mol Sci</source> (<year>2023</year>) <volume>24</volume>:<elocation-id>9919</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms24129919</pub-id>
</citation>
</ref>
<ref id="B41">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koushyar</surname> <given-names>S</given-names>
</name>
<name>
<surname>Economides</surname> <given-names>G</given-names>
</name>
<name>
<surname>Zaat</surname> <given-names>S</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>W</given-names>
</name>
<name>
<surname>Bevan</surname> <given-names>CL</given-names>
</name>
<name>
<surname>Dart</surname> <given-names>DA</given-names>
</name>
</person-group>. <article-title>The prohibitin-repressive interaction with E2F1 is rapidly inhibited by androgen signalling in prostate cancer cells</article-title>. <source>Oncogenesis</source> (<year>2017</year>) <volume>6</volume>:<page-range>e333&#x2013;3</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/oncsis.2017.32</pub-id>
</citation>
</ref>
<ref id="B42">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nusse</surname> <given-names>R</given-names>
</name>
<name>
<surname>Clevers</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Wnt/&#x3b2;-catenin signaling, disease, and emerging therapeutic modalities</article-title>. <source>Cell</source> (<year>2017</year>) <volume>169</volume>:<page-range>985&#x2013;99</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cell.2017.05.016</pub-id>
</citation>
</ref>
<ref id="B43">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>VSW</given-names>
</name>
<name>
<surname>Ng</surname> <given-names>SS</given-names>
</name>
<name>
<surname>Boersema</surname> <given-names>PJ</given-names>
</name>
<name>
<surname>Low</surname> <given-names>TY</given-names>
</name>
<name>
<surname>Karthaus</surname> <given-names>WR</given-names>
</name>
<name>
<surname>Gerlach</surname> <given-names>JP</given-names>
</name>
<etal/>
</person-group>. <article-title>Wnt signaling through inhibition of &#x3b2;-catenin degradation in an intact axin1 complex</article-title>. <source>Cell</source> (<year>2012</year>) <volume>149</volume>:<page-range>1245&#x2013;56</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cell.2012.05.002</pub-id>
</citation>
</ref>
<ref id="B44">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fujimuro</surname> <given-names>M</given-names>
</name>
<name>
<surname>Hayward</surname> <given-names>SD</given-names>
</name>
</person-group>. <article-title>The latency-associated nuclear antigen of kaposi&#x2019;s sarcoma-associated herpesvirus manipulates the activity of glycogen synthase kinase-3&#x3b2;</article-title>. <source>J Virol</source> (<year>2003</year>) <volume>77</volume>:<page-range>8019&#x2013;30</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/JVI.77.14.8019&#x2013;8030.2003</pub-id>
</citation>
</ref>
<ref id="B45">
<label>45</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morrison</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Klingelhutz</surname> <given-names>AJ</given-names>
</name>
<name>
<surname>Raab-Traub</surname> <given-names>N</given-names>
</name>
</person-group>. <article-title>Epstein-Barr virus latent membrane protein 2a activates &#x3b2;-catenin signaling in epithelial cells</article-title>. <source>J Virol</source> (<year>2003</year>) <volume>77</volume>:<page-range>12276&#x2013;84</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/JVI.77.22.12276-12284.2003</pub-id>
</citation>
</ref>
<ref id="B46">
<label>46</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Daud</surname> <given-names>M</given-names>
</name>
<name>
<surname>Rana</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Husnain</surname> <given-names>T</given-names>
</name>
<name>
<surname>Ijaz</surname> <given-names>B</given-names>
</name>
</person-group>. <article-title>Modulation of Wnt signaling pathway by hepatitis B virus</article-title>. <source>Arch Virol</source> (<year>2017</year>) <volume>162</volume>:<page-range>2937&#x2013;47</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00705-017-3462-6</pub-id>
</citation>
</ref>
<ref id="B47">
<label>47</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qiao</surname> <given-names>DD</given-names>
</name>
<name>
<surname>He</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Cheng</surname> <given-names>XW</given-names>
</name>
<name>
<surname>Yao</surname> <given-names>YX</given-names>
</name>
<name>
<surname>Nair</surname> <given-names>V</given-names>
</name>
<name>
<surname>Shao</surname> <given-names>HX</given-names>
</name>
<etal/>
</person-group>. <article-title>Regulation of avian leukosis virus subgroup J replication by Wnt/&#x3b2;-catenin signaling pathway</article-title>. <source>Viruses</source> (<year>2021</year>) <volume>13</volume>:<elocation-id>1968</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/v13101968</pub-id>
</citation>
</ref>
<ref id="B48">
<label>48</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname> <given-names>LQ</given-names>
</name>
<name>
<surname>Thunuguntla</surname> <given-names>P</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>YL</given-names>
</name>
<name>
<surname>Hancock</surname> <given-names>M</given-names>
</name>
<name>
<surname>Jones</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>The &#x3b2;-catenin signaling pathway stimulates bovine herpesvirus 1 productive infection</article-title>. <source>Virology</source> (<year>2017</year>) <volume>500</volume>:<page-range>91&#x2013;5</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.virol.2016.10.014</pub-id>
</citation>
</ref>
<ref id="B49">
<label>49</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taipale</surname> <given-names>J</given-names>
</name>
<name>
<surname>Beachy</surname> <given-names>PA</given-names>
</name>
</person-group>. <article-title>The Hedgehog and Wnt signalling pathways in cancer</article-title>. <source>Nature</source> (<year>2001</year>) <volume>411</volume>:<page-range>349&#x2013;54</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/35077219</pub-id>
</citation>
</ref>
<ref id="B50">
<label>50</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wickstr&#xf6;m</surname> <given-names>M</given-names>
</name>
<name>
<surname>Dyberg</surname> <given-names>C</given-names>
</name>
<name>
<surname>Shimokawa</surname> <given-names>T</given-names>
</name>
<name>
<surname>Milosevic</surname> <given-names>J</given-names>
</name>
<name>
<surname>Baryawno</surname> <given-names>N</given-names>
</name>
<name>
<surname>Fuskev&#xe5;g</surname> <given-names>OM</given-names>
</name>
<etal/>
</person-group>. <article-title>Targeting the hedgehog signal transduction pathway at the level of GLI inhibits neuroblastoma cell growth in <italic>vitro</italic> and in <italic>vivo</italic>
</article-title>. <source>Int J Cancer</source> (<year>2013</year>) <volume>132</volume>:<page-range>1516&#x2013;24</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/ijc.27820</pub-id>
</citation>
</ref>
<ref id="B51">
<label>51</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>FH</given-names>
</name>
<name>
<surname>Duman-Scheel</surname> <given-names>M</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>D</given-names>
</name>
<name>
<surname>Du</surname> <given-names>W</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>CC</given-names>
</name>
<etal/>
</person-group>. <article-title>Sonic hedgehog signaling induces vascular smooth muscle cell proliferation via induction of the G<sub>1</sub> cyclin-retinoblastoma axis</article-title>. <source>Arterioscler Thromb Vasc Biol</source> (<year>2010</year>) <volume>30</volume>:<page-range>1787&#x2013;94</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1161/ATVBAHA.110.208520</pub-id>
</citation>
</ref>
<ref id="B52">
<label>52</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kramann</surname> <given-names>R</given-names>
</name>
<name>
<surname>Fleig</surname> <given-names>SV</given-names>
</name>
<name>
<surname>Schneider</surname> <given-names>RK</given-names>
</name>
<name>
<surname>Fabian</surname> <given-names>SL</given-names>
</name>
<name>
<surname>DiRocco</surname> <given-names>DP</given-names>
</name>
<name>
<surname>Maarouf</surname> <given-names>O</given-names>
</name>
<etal/>
</person-group>. <article-title>Pharmacological GLI2 inhibition prevents myofibroblast cell-cycle progression and reduces kidney fibrosis</article-title>. <source>J Clin Invest</source> (<year>2015</year>) <volume>125</volume>:<page-range>2935&#x2013;51</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1172/JCI74929</pub-id>
</citation>
</ref>
<ref id="B53">
<label>53</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nagao</surname> <given-names>H</given-names>
</name>
<name>
<surname>Ijiri</surname> <given-names>K</given-names>
</name>
<name>
<surname>Hirotsu</surname> <given-names>M</given-names>
</name>
<name>
<surname>Ishidou</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Yamamoto</surname> <given-names>T</given-names>
</name>
<name>
<surname>Nagano</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Role of GLI2 in the growth of human osteosarcoma: GLI2 in osteosarcoma</article-title>. <source>J Pathol</source> (<year>2011</year>) <volume>224</volume>:<page-range>169&#x2013;79</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/path.2880</pub-id>
</citation>
</ref>
<ref id="B54">
<label>54</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname> <given-names>HY</given-names>
</name>
<name>
<surname>Xia</surname> <given-names>L</given-names>
</name>
<name>
<surname>Shen</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>MH</given-names>
</name>
<name>
<surname>Gu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Bouamar</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Differential effects of GLI2 and GLI3 in regulating cervical cancer Malignancy in <italic>vitro</italic> and in <italic>vivo</italic>
</article-title>. <source>Lab Invest</source> (<year>2018</year>) <volume>98</volume>:<page-range>1384&#x2013;96</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41374-018-0089-5</pub-id>
</citation>
</ref>
<ref id="B55">
<label>55</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>DW</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>JP</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>J</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>T</given-names>
</name>
</person-group>. <article-title>shRNA-mediated silencing of Gli2 gene inhibits proliferation and sensitizes human hepatocellular carcinoma cells towards TRAIL-induced apoptosis</article-title>. <source>J Cell Biochem</source> (<year>2011</year>) <volume>112</volume>:<page-range>3140&#x2013;50</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/jcb.23240</pub-id>
</citation>
</ref>
<ref id="B56">
<label>56</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname> <given-names>HY</given-names>
</name>
<name>
<surname>Cho</surname> <given-names>HK</given-names>
</name>
<name>
<surname>Hong</surname> <given-names>SP</given-names>
</name>
<name>
<surname>Cheong</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Hepatitis B virus X protein stimulates the Hedgehog&#x2013;Gli activation through protein stabilization and nuclear localization of Gli1 in liver cancer cells</article-title>. <source>Cancer Lett</source> (<year>2011</year>) <volume>309</volume>:<page-range>176&#x2013;84</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.canlet.2011.05.033</pub-id>
</citation>
</ref>
<ref id="B57">
<label>57</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jaiswal</surname> <given-names>A</given-names>
</name>
<name>
<surname>Singh</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>Homeostases of epidermis and hair follicle, and development of basal cell carcinoma</article-title>. <source>Biochim Biophys Acta Rev Cancer</source> (<year>2022</year>) <volume>1877</volume>:<elocation-id>188795</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.bbcan.2022.188795</pub-id>
</citation>
</ref>
<ref id="B58">
<label>58</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vafaizadeh</surname> <given-names>V</given-names>
</name>
<name>
<surname>Buechel</surname> <given-names>D</given-names>
</name>
<name>
<surname>Rubinstein</surname> <given-names>N</given-names>
</name>
<name>
<surname>Kalathur</surname> <given-names>RKR</given-names>
</name>
<name>
<surname>Bazzani</surname> <given-names>L</given-names>
</name>
<name>
<surname>Saxena</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>The interactions of Bcl9/Bcl9L with &#x3b2;-catenin and Pygopus promote breast cancer growth, invasion, and metastasis</article-title>. <source>Oncogene</source> (<year>2021</year>) <volume>40</volume>:<page-range>6195&#x2013;209</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41388-021-02016-9</pub-id>
</citation>
</ref>
<ref id="B59">
<label>59</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chetaille</surname> <given-names>B</given-names>
</name>
<name>
<surname>Bertucci</surname> <given-names>F</given-names>
</name>
<name>
<surname>Finetti</surname> <given-names>P</given-names>
</name>
<name>
<surname>Esterni</surname> <given-names>B</given-names>
</name>
<name>
<surname>Stamatoullas</surname> <given-names>A</given-names>
</name>
<name>
<surname>Picquenot</surname> <given-names>JM</given-names>
</name>
<etal/>
</person-group>. <article-title>Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome</article-title>. <source>Blood</source> (<year>2009</year>) <volume>113</volume>:<fpage>2765</fpage>&#x2013;<lpage>3775</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1182/blood-2008-07-168096</pub-id>
</citation>
</ref>
<ref id="B60">
<label>60</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kirkin</surname> <given-names>V</given-names>
</name>
<name>
<surname>Joos</surname> <given-names>S</given-names>
</name>
<name>
<surname>Z&#xf6;rnig</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>The role of Bcl-2 family members in tumorigenesis</article-title>. <source>Biochim Biophys Acta</source> (<year>2004</year>) <volume>1644</volume>:<page-range>229&#x2013;49</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.bbamcr.2003.08.009</pub-id>
</citation>
</ref>
<ref id="B61">
<label>61</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Albalawi</surname> <given-names>YA</given-names>
</name>
<name>
<surname>Narasipura</surname> <given-names>SD</given-names>
</name>
<name>
<surname>Al-Harthi</surname> <given-names>L</given-names>
</name>
</person-group>. <article-title>Wnt/&#x3b2;-catenin protects lymphocytes from HIV-mediated apoptosis via induction of Bcl-xL</article-title>. <source>Viruses</source> (<year>2022</year>) <volume>14</volume>:<elocation-id>1469</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/v140714699</pub-id>
</citation>
</ref>
<ref id="B62">
<label>62</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Essbauer</surname> <given-names>S</given-names>
</name>
<name>
<surname>Fischer</surname> <given-names>U</given-names>
</name>
<name>
<surname>Bergmann</surname> <given-names>S</given-names>
</name>
<name>
<surname>Ahne</surname> <given-names>W</given-names>
</name>
</person-group>. <article-title>Investigations on the ORF 167L of lymphocystis disease virus (<italic>Iridoviridae</italic>)</article-title>. <source>Virus Genes</source> (<year>2004</year>) <volume>28</volume>:<fpage>19</fpage>&#x2013;<lpage>39</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1023/B:VIRU.0000012261.96217.fe</pub-id>
</citation>
</ref>
<ref id="B63">
<label>63</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Najbauer</surname> <given-names>EE</given-names>
</name>
<name>
<surname>Becker</surname> <given-names>S</given-names>
</name>
<name>
<surname>Giller</surname> <given-names>K</given-names>
</name>
<name>
<surname>Zweckstetter</surname> <given-names>M</given-names>
</name>
<name>
<surname>Lange</surname> <given-names>A</given-names>
</name>
<name>
<surname>Steinem</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Structure, gating and interactions of the voltage-dependent anion channel</article-title>. <source>Eur Biophys J</source> (<year>2021</year>) <volume>50</volume>:<page-range>159&#x2013;72</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00249-021-01515-7</pub-id>
</citation>
</ref>
<ref id="B64">
<label>64</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saadawy</surname> <given-names>AH</given-names>
</name>
<name>
<surname>Khalil</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Sidarous</surname> <given-names>LR</given-names>
</name>
<name>
<surname>Ibrahim</surname> <given-names>MS</given-names>
</name>
<name>
<surname>Salem</surname> <given-names>TZ</given-names>
</name>
</person-group>. <article-title>Voltage-dependent anion channels: key players in viral infection</article-title>. <source>Rev Med Virol</source> (<year>2023</year>) <volume>33</volume>:<fpage>e2453</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/rmv.2453</pub-id>
</citation>
</ref>
<ref id="B65">
<label>65</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chin</surname> <given-names>HS</given-names>
</name>
<name>
<surname>Li</surname> <given-names>MX</given-names>
</name>
<name>
<surname>Tan</surname> <given-names>IKL</given-names>
</name>
<name>
<surname>Ninnis</surname> <given-names>RL</given-names>
</name>
<name>
<surname>Reljic</surname> <given-names>B</given-names>
</name>
<name>
<surname>Scicluna</surname> <given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>VDAC2 enables BAX to mediate apoptosis and limit tumor development</article-title>. <source>Nat Commun</source> (<year>2018</year>) <volume>9</volume>:<fpage>4976</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41467-018-07309-4</pub-id>
</citation>
</ref>
<ref id="B66">
<label>66</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Breckenridge</surname> <given-names>DG</given-names>
</name>
<name>
<surname>Xue</surname> <given-names>D</given-names>
</name>
</person-group>. <article-title>Regulation of mitochondrial membrane permeabilization by BCL-2 family proteins and caspases</article-title>. <source>Curr Opin Cell Biol</source> (<year>2004</year>) <volume>16</volume>:<page-range>647&#x2013;52</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ceb.2004.09.009</pub-id>
</citation>
</ref>
<ref id="B67">
<label>67</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname> <given-names>WC</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>ZQ</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>ZC</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>B</given-names>
</name>
<name>
<surname>Li</surname> <given-names>XQ</given-names>
</name>
<name>
<surname>Cao</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>The association of receptor of activated protein kinase c 1(RACK1) with infectious bursal disease virus viral protein VP5 and voltage-dependent anion channel 2 (VDAC2) inhibits apoptosis and enhances viral replication</article-title>. <source>J Biol Chem</source> (<year>2015</year>) <volume>290</volume>:<page-range>8500&#x2013;10</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.M114.585687</pub-id>
</citation>
</ref>
<ref id="B68">
<label>68</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wesche</surname> <given-names>J</given-names>
</name>
<name>
<surname>Haglund</surname> <given-names>K</given-names>
</name>
<name>
<surname>Haugsten</surname> <given-names>EM</given-names>
</name>
</person-group>. <article-title>Fibroblast growth factors and their receptors in cancer</article-title>. <source>Biochem J</source> (<year>2011</year>) <volume>437</volume>:<fpage>199</fpage>&#x2013;<lpage>213</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1042/BJ20101603</pub-id>
</citation>
</ref>
<ref id="B69">
<label>69</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kawase</surname> <given-names>R</given-names>
</name>
<name>
<surname>Ishiwata</surname> <given-names>T</given-names>
</name>
<name>
<surname>Matsuda</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Onda</surname> <given-names>M</given-names>
</name>
<name>
<surname>Kudo</surname> <given-names>M</given-names>
</name>
<name>
<surname>Takeshita</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Expression of fibroblast growth factor receptor 2 IIIc in human uterine cervical intraepithelial neoplasia and cervical cancer</article-title>. <source>Int J Oncol</source> (<year>2009</year>) <volume>36</volume>:<page-range>331&#x2013;40</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3892/ijo_00000504</pub-id>
</citation>
</ref>
<ref id="B70">
<label>70</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ren</surname> <given-names>SL</given-names>
</name>
<name>
<surname>Gaykalova</surname> <given-names>DA</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>T</given-names>
</name>
<name>
<surname>Favorov</surname> <given-names>AV</given-names>
</name>
<name>
<surname>Fertig</surname> <given-names>EJ</given-names>
</name>
<name>
<surname>Tamayo</surname> <given-names>P</given-names>
</name>
<etal/>
</person-group>. <article-title>HPV E2, E4, E5 drive alternative carcinogenic pathways in HPV positive cancers</article-title>. <source>Oncogene</source> (<year>2020</year>) <volume>39</volume>:<page-range>6327&#x2013;39</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41388-020-01431-8</pub-id>
</citation>
</ref>
<ref id="B71">
<label>71</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chesi</surname> <given-names>M</given-names>
</name>
<name>
<surname>Nardini</surname> <given-names>E</given-names>
</name>
<name>
<surname>Brents</surname> <given-names>LA</given-names>
</name>
<name>
<surname>Schr&#xf6;ck</surname> <given-names>E</given-names>
</name>
<name>
<surname>Ried</surname> <given-names>T</given-names>
</name>
<name>
<surname>Kuehl</surname> <given-names>WM</given-names>
</name>
<etal/>
</person-group>. <article-title>Frequent translocation t(4, 14)(p16.3; q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3</article-title>. <source>Nat Genet</source> (<year>1997</year>) <volume>16</volume>:<page-range>260&#x2013;4</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ng0797-260</pub-id>
</citation>
</ref>
<ref id="B72">
<label>72</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Richelda</surname> <given-names>R</given-names>
</name>
<name>
<surname>Ronchetti</surname> <given-names>D</given-names>
</name>
<name>
<surname>Baldini</surname> <given-names>L</given-names>
</name>
<name>
<surname>Cro</surname> <given-names>L</given-names>
</name>
<name>
<surname>Viggiano</surname> <given-names>L</given-names>
</name>
<name>
<surname>Marzella</surname> <given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>A novel chromosomal translocation t(4, 14)(p16.3; q32) in multiple myeloma involves the fibroblast growth-factor receptor 3 gene</article-title>. <source>Blood</source> (<year>1997</year>) <volume>90</volume>:<page-range>4062&#x2013;70</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1182/blood.V90.10.4062</pub-id>
</citation>
</ref>
<ref id="B73">
<label>73</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jha</surname> <given-names>HC</given-names>
</name>
<name>
<surname>Banerjee</surname> <given-names>S</given-names>
</name>
<name>
<surname>Robertson</surname> <given-names>E</given-names>
</name>
</person-group>. <article-title>The role of gammaherpesviruses in cancer pathogenesis</article-title>. <source>Pathogens</source> (<year>2016</year>) <volume>5</volume>:<elocation-id>18</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/pathogens5010018</pub-id>
</citation>
</ref>
<ref id="B74">
<label>74</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goradia</surname> <given-names>A</given-names>
</name>
<name>
<surname>Bayerl</surname> <given-names>M</given-names>
</name>
<name>
<surname>Cornfield</surname> <given-names>D</given-names>
</name>
</person-group>. <article-title>The 8p11 Myeloproliferative syndrome: review of literature and an illustrative case report</article-title>. <source>Int J Clin Exp Pathol</source> (<year>2008</year>) <volume>1</volume>:<page-range>448&#x2013;56</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/14992020802286202</pub-id>
</citation>
</ref>
<ref id="B75">
<label>75</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blackburn</surname> <given-names>SD</given-names>
</name>
<name>
<surname>Steadman</surname> <given-names>RA</given-names>
</name>
<name>
<surname>Johnson</surname> <given-names>FB</given-names>
</name>
</person-group>. <article-title>Attachment of adeno-associated virus type 3H to fibroblast growth factor receptor 1</article-title>. <source>Arch Virol</source> (<year>2006</year>) <volume>151</volume>:<page-range>617&#x2013;23</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00705-005-0650-6</pub-id>
</citation>
</ref>
<ref id="B76">
<label>76</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Br&#xe9;chot</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>Pathogenesis of hepatitis B virus&#x2014;related hepatocellular carcinoma: old and new paradigms</article-title>. <source>Gastroenterology</source> (<year>2004</year>) <volume>127</volume>:<page-range>S56&#x2013;61</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1053/j.gastro.2004.09.016</pub-id>
</citation>
</ref>
<ref id="B77">
<label>77</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Becker</surname> <given-names>JC</given-names>
</name>
<name>
<surname>Stang</surname> <given-names>A</given-names>
</name>
<name>
<surname>DeCaprio</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Cerroni</surname> <given-names>L</given-names>
</name>
<name>
<surname>Lebb&#xe9;</surname> <given-names>C</given-names>
</name>
<name>
<surname>Veness</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Merkel cell carcinoma</article-title>. <source>Nat Rev Dis Primers</source> (<year>2017</year>) <volume>3</volume>:<fpage>17077</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nrdp.2017.77</pub-id>
</citation>
</ref>
<ref id="B78">
<label>78</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wendzicki</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Moore</surname> <given-names>PS</given-names>
</name>
<name>
<surname>Chang</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>Large T and small T antigens of Merkel cell polyomavirus</article-title>. <source>Curr Opin Virol</source> (<year>2015</year>) <volume>11</volume>:<fpage>38</fpage>&#x2013;<lpage>43</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.coviro.2015.01.009</pub-id>
</citation>
</ref>
<ref id="B79">
<label>79</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vande Pol</surname> <given-names>SB</given-names>
</name>
<name>
<surname>Klingelhutz</surname> <given-names>AJ</given-names>
</name>
</person-group>. <article-title>Papillomavirus E6 oncoproteins</article-title>. <source>Virology</source> (<year>2013</year>) <volume>445</volume>:<page-range>115&#x2013;37</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.virol.2013.04.026</pub-id>
</citation>
</ref>
<ref id="B80">
<label>80</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roman</surname> <given-names>A</given-names>
</name>
<name>
<surname>Munger</surname> <given-names>K</given-names>
</name>
</person-group>. <article-title>The papillomavirus E7 proteins</article-title>. <source>Virology</source> (<year>2013</year>) <volume>445</volume>:<page-range>138&#x2013;68</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.virol.2013.04.013</pub-id>
</citation>
</ref>
<ref id="B81">
<label>81</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dawson</surname> <given-names>CW</given-names>
</name>
<name>
<surname>Laverick</surname> <given-names>L</given-names>
</name>
<name>
<surname>Morris</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Tramoutanis</surname> <given-names>G</given-names>
</name>
<name>
<surname>Young</surname> <given-names>LS</given-names>
</name>
</person-group>. <article-title>Epstein-Barr virus-encoded LMP1 regulates epithelial cell motility and invasion via the ERK-MAPK pathway</article-title>. <source>J Virol</source> (<year>2008</year>) <volume>82</volume>:<page-range>3654&#x2013;64</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/JVI.01888-07</pub-id>
</citation>
</ref>
<ref id="B82">
<label>82</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McCormick</surname> <given-names>C</given-names>
</name>
<name>
<surname>Ganem</surname> <given-names>D</given-names>
</name>
</person-group>. <article-title>The Kaposin B protein of KSHV activates the p38/MK2 pathway and stabilizes cytokine mRNAs</article-title>. <source>Science</source> (<year>2005</year>) <volume>307</volume>:<page-range>739&#x2013;41</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/science.1105779</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>